<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2d1 20170631//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article" dtd-version="1.2d1" specific-use="production" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BIORXIV</journal-id>
<journal-title-group>
<journal-title>bioRxiv</journal-title>
<abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title>
</journal-title-group>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1101/124180</article-id>
<article-version>1.1</article-version>
<article-categories>
<subj-group subj-group-type="author-type">
<subject>Regular Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>New Results</subject>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Neuroscience</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson&#x2019;s disease: implications for its aetiology</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9108-2384</contrib-id>
<name>
<surname>Pretorius</surname>
<given-names>Etheresia</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1399-5601</contrib-id>
<name>
<surname>Mbotwe</surname>
<given-names>Sthembile</given-names></name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5838-7963</contrib-id>
<name>
<surname>Kell</surname>
<given-names>Douglas B.</given-names></name>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="aff" rid="a4">4</xref>
<xref ref-type="aff" rid="a5">5</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Department of Physiological Sciences, Stellenbosch University</institution>, 7602, <country>South Africa</country>.</aff>
<aff id="a2"><label>2</label><institution>Department of Physiology, Faculty of Health Sciences, University of Pretoria</institution>, Arcadia 0007, <country>South Africa</country>.</aff>
<aff id="a3"><label>3</label><institution>School of Chemistry</institution>,</aff>
<aff id="a4"><label>4</label><institution>The Manchester Institute of Biotechnology</institution>,</aff>
<aff id="a5"><label>5</label><institution>Centre for Synthetic Biology of Fine and Speciality Chemicals, The University of Manchester</institution>, 131 Princess St, MANCHESTER M1 7DN, Lancs, <country>UK</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label><bold>Corresponding authors: Etheresia Pretorius</bold>, Department of Physiological Sciences, Stellenbosch University, Private Bag X1 MATIELAND, 7602, SOUTH AFRICA, <email>resiap@sun.ac.za</email>, Tel: (&#x002B;27)829295041 <bold>Douglas B. Kell</bold> School of Chemistry and The Manchester Institute of Biotechnology, The University of Manchester, 131, Princess St, MANCHESTER M1 7DN, Lancs, UK, <email>dbk@manchester.ac.uk</email>, Tel: (&#x002B;44)161 306 4492</corresp>
</author-notes>
<pub-date pub-type="epub">
<year>2017</year>
</pub-date>
<elocation-id>124180</elocation-id>
<history>
<date date-type="received">
<day>04</day>
<month>4</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>4</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2017, Posted by Cold Spring Harbor Laboratory</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p></license>
</permissions>
<self-uri xlink:href="124180.pdf" content-type="pdf" xlink:role="full-text"/>
<abstract>
<title>Abstract</title>
<p>The thrombin-induced polymerisation of fibrinogen to form fibrin is well established as a late stage of blood clotting. In recent work, we showed that the presence of tiny amounts of bacterial lipopolysaccharide (LPS) could cause these clots to adopt an amyloid form, that could be observed via scanning electron microscopy (SEM) or via the fluorescence of thioflavin-T. This could be prevented by the prior addition of lipopolysaccharide-binding protein (LBP). We had also observed by SEM this unusual clotting in the blood of patients with Parkinson&#x2019;s disease (PD). We here show that this too can be prevented by LBP, thereby implicating such inflammatory microbial cell wall products in the aetiology of the disease. This may lead to novel treatment strategies in PD designed to target microbes and their products.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>Thrombin</kwd>
<kwd>fibrin(ogen) clotting</kwd>
<kwd>LPS</kwd>
<kwd>LBP</kwd>
<kwd>thioflavin-T</kwd>
</kwd-group>
<counts>
<page-count count="21"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>It is widely recognised that that many chronic, inflammatory diseases are accompanied by insoluble amyloid fibril formation (<xref ref-type="bibr" rid="c13">Chiti and Dobson, 2006</xref>; <xref ref-type="bibr" rid="c32">Herczenik and Gebbink, 2008</xref>; <xref ref-type="bibr" rid="c95">Rambaran and Serpell, 2008</xref>; <xref ref-type="bibr" rid="c22">Eisenberg and Jucker, 2012</xref>; <xref ref-type="bibr" rid="c62">Knowles et al., 2014</xref>; <xref ref-type="bibr" rid="c107">Tipping et al., 2015</xref>; <xref ref-type="bibr" rid="c96">Riek and Eisenberg, 2016</xref>). Thus, Parkinson&#x2019;s (PD) is accompanied by amyloid forms of &#x03B1;-synuclein in the substantia nigra pars compacta (<xref ref-type="bibr" rid="c111">Uversky et al., 2001</xref>; <xref ref-type="bibr" rid="c113">Vilar et al., 2008</xref>; <xref ref-type="bibr" rid="c72">Olanow and Brundin, 2013</xref>; <xref ref-type="bibr" rid="c41">Kalia and Kalia, 2015</xref>; <xref ref-type="bibr" rid="c43">Kalia and Lang, 2015</xref>; <xref ref-type="bibr" rid="c99">Sampson et al., 2016</xref>). To this end, systems biology approaches (<xref ref-type="bibr" rid="c4">Antony et al., 2013</xref>; <xref ref-type="bibr" rid="c26">Funke et al., 2013</xref>; <xref ref-type="bibr" rid="c38">Jones et al., 2013</xref>; <xref ref-type="bibr" rid="c25">Fujita et al., 2014</xref>; <xref ref-type="bibr" rid="c63">Krishna et al., 2014</xref>) have made considerable headway in accounting for the known &#x201C;Parkinson&#x2019;s&#x201D; genes in biochemical terms, with the additional recognition that iron dysregulation is also a major contributor to disease progression (<xref ref-type="bibr" rid="c18">Double et al., 2000</xref>; <xref ref-type="bibr" rid="c64">Levenson, 2003</xref>; <xref ref-type="bibr" rid="c37">Jones et al., 2007</xref>; <xref ref-type="bibr" rid="c6">Barnham and Bush, 2008</xref>; <xref ref-type="bibr" rid="c28">Gerlach et al., 2008</xref>; <xref ref-type="bibr" rid="c75">Perez et al., 2008</xref>; <xref ref-type="bibr" rid="c1">Altamura and Muckenthaler, 2009</xref>; <xref ref-type="bibr" rid="c48">Kell, 2009</xref>; <xref ref-type="bibr" rid="c49">Kell, 2010</xref>; <xref ref-type="bibr" rid="c36">Jameson, 2011</xref>; <xref ref-type="bibr" rid="c73">Oshiro et al., 2011</xref>; <xref ref-type="bibr" rid="c115">Weinreb et al., 2013</xref>; <xref ref-type="bibr" rid="c54">Kell and Pretorius, 2014</xref>).</p>
<p>It is rather less widely recognised that PD is also accompanied by major changes in the normal clotting of blood, i. e. it is a coagulopathy (<xref ref-type="bibr" rid="c100">Sato et al., 2003</xref>; <xref ref-type="bibr" rid="c98">Rosenbaum et al., 2013</xref>; <xref ref-type="bibr" rid="c90">Pretorius et al., 2014c</xref>; <xref ref-type="bibr" rid="c34">Infante et al., 2016</xref>).</p>
<p>When thrombin is added to the platelet poor plasma (PPP) of healthy controls, the fibres forming the subsequent clot appear like a plate of noodles or spaghetti in the scanning electron microscope (<xref ref-type="bibr" rid="c12">Campbell et al., 2010</xref>; <xref ref-type="bibr" rid="c89">Pretorius et al., 2011b</xref>; <xref ref-type="bibr" rid="c114">Weigandt et al., 2012</xref>; <xref ref-type="bibr" rid="c8">Bester et al., 2015</xref>; <xref ref-type="bibr" rid="c56">Kell and Pretorius, 2015b</xref>). However, we and others have observed that their diameter and morphology changes markedly in a variety of vascular and inflammatory diseases, typically producing &#x2018;dense matter deposits&#x2019; (e.g. (<xref ref-type="bibr" rid="c39">J&#x00F6;rneskog et al., 1996</xref>; <xref ref-type="bibr" rid="c19">Dunn and Ari&#x00EB;ns, 2004</xref>; <xref ref-type="bibr" rid="c20">Dunn et al., 2005</xref>; <xref ref-type="bibr" rid="c21">Dunn et al., 2006</xref>; <xref ref-type="bibr" rid="c77">Pieters et al., 2006</xref>; <xref ref-type="bibr" rid="c2">Alzahrani and Ajjan, 2010</xref>; <xref ref-type="bibr" rid="c87">Pretorius et al., 2011a</xref>; <xref ref-type="bibr" rid="c89">Pretorius et al., 2011b</xref>; <xref ref-type="bibr" rid="c3">Alzahrani et al., 2012</xref>; <xref ref-type="bibr" rid="c84">Pretorius and Kell, 2014</xref>; <xref ref-type="bibr" rid="c81">Pretorius et al., 2015</xref>)).</p>
<p>Thrombin removes two fibrinopeptides from fibrinogen, thereby allowing the fibrinogen to self-assemble into insoluble fibrin via a &#x2018;knobs and holes&#x2019; mechanism (e.g. (<xref ref-type="bibr" rid="c116">Weisel, 2005</xref>; <xref ref-type="bibr" rid="c117">Wolberg, 2007</xref>; <xref ref-type="bibr" rid="c14">Cilia La Corte et al., 2011</xref>; <xref ref-type="bibr" rid="c110">Undas and Ari&#x00EB;ns, 2011</xref>; <xref ref-type="bibr" rid="c118">Wolberg, 2012</xref>)). There are not otherwise considered to be any major changes in secondary structure (<xref ref-type="bibr" rid="c116">Weisel, 2005</xref>; <xref ref-type="bibr" rid="c5">Averett et al., 2008</xref>; <xref ref-type="bibr" rid="c119">Yermolenko et al., 2011</xref>; <xref ref-type="bibr" rid="c94">Protopopova et al., 2015</xref>). A final crosslinking step catalysed by Factor XIII (after it too has been activated by thrombin) (<xref ref-type="bibr" rid="c15">Dickneite et al., 2015</xref>) increases the stability of the clot.</p>
<p>A very specific feature of amyloid proteins is the formation of a cross-&#x03B2;-sheet structure, perpendicular to the fibres with a characteristic spacing (observable in X-ray reflections) of 4.7-4.8&#x00C5; (e.g. (<xref ref-type="bibr" rid="c68">Maji et al., 2009</xref>; <xref ref-type="bibr" rid="c22">Eisenberg and Jucker, 2012</xref>; <xref ref-type="bibr" rid="c109">Tycko and Wickner, 2013</xref>; <xref ref-type="bibr" rid="c96">Riek and Eisenberg, 2016</xref>)). In contrast to normal structures, thioflavin T binds strongly to them, and fluoresces strongly at 480-520nm when excited at &#x007E;440 nm (e.g. (<xref ref-type="bibr" rid="c65">LeVine, 1999</xref>; <xref ref-type="bibr" rid="c11">Biancalana et al., 2009</xref>; <xref ref-type="bibr" rid="c10">Biancalana and Koide, 2010</xref>; <xref ref-type="bibr" rid="c29">Groenning, 2010</xref>; <xref ref-type="bibr" rid="c106">Sulatskaya et al., 2011</xref>; <xref ref-type="bibr" rid="c23">Freire et al., 2014</xref>)).</p>
<p>Although it can become so in the presence of a rare mutation in the fibrinogen a chain (<xref ref-type="bibr" rid="c103">Serpell et al., 2007</xref>; <xref ref-type="bibr" rid="c76">Picken, 2010</xref>; <xref ref-type="bibr" rid="c104">Stangou et al., 2010</xref>; <xref ref-type="bibr" rid="c30">Haidinger et al., 2013</xref>)), or by extreme mechanical stretching (<xref ref-type="bibr" rid="c120">Zhmurov et al., 2011</xref>; <xref ref-type="bibr" rid="c67">Litvinov et al., 2012</xref>; <xref ref-type="bibr" rid="c121">Zhmurov et al., 2012</xref>), fibrinogen is not considered to be amyloidogenic, nor is fibrin seen as an amyloid protein. However, following many observations in the SEM of anomalous blood clotting (e.g. (<xref ref-type="bibr" rid="c93">Pretorius et al., 2013b</xref>; <xref ref-type="bibr" rid="c54">Kell and Pretorius, 2014</xref>; <xref ref-type="bibr" rid="c82">Pretorius et al., 2014a</xref>; <xref ref-type="bibr" rid="c84">Pretorius and Kell, 2014</xref>; <xref ref-type="bibr" rid="c8">Bester et al., 2015</xref>; <xref ref-type="bibr" rid="c56">Kell and Pretorius, 2015b</xref>; <xref ref-type="bibr" rid="c81">Pretorius et al., 2015</xref>; <xref ref-type="bibr" rid="c86">Pretorius et al., 2016d</xref>)), we have recently established (<xref ref-type="bibr" rid="c58">Kell and Pretorius, 2016b</xref>; <xref ref-type="bibr" rid="c57">a</xref>; <xref ref-type="bibr" rid="c85">Pretorius et al., 2016c</xref>; <xref ref-type="bibr" rid="c86">Pretorius et al., 2016d</xref>) that this anomalous clotting is in fact amyloid in nature.</p>
<p>Dormant bacteria are widespread in nature (<xref ref-type="bibr" rid="c44">Kaprelyants et al., 1993</xref>; <xref ref-type="bibr" rid="c17">Domingue and Woody, 1997</xref>; <xref ref-type="bibr" rid="c50">Kell et al., 1998</xref>; <xref ref-type="bibr" rid="c69">Mattman, 2001</xref>; <xref ref-type="bibr" rid="c16">Domingue, 2010</xref>), and we have argued strongly for a role for dormant bacteria in the aetiology of such diseases (<xref ref-type="bibr" rid="c53">Kell et al., 2015</xref>; <xref ref-type="bibr" rid="c55">Kell and Pretorius, 2015a</xref>; <xref ref-type="bibr" rid="c78">Potgieter et al., 2015</xref>; <xref ref-type="bibr" rid="c35">Itzhaki et al., 2016</xref>; <xref ref-type="bibr" rid="c52">Kell and Kenny, 2016b</xref>; <xref ref-type="bibr" rid="c59">Kell and Pretorius, 2016c</xref>; <xref ref-type="bibr" rid="c79">Pretorius et al., 2016a</xref>; <xref ref-type="bibr" rid="c80">Pretorius et al., 2016b</xref>). In the recent analysis, amyloid formation occurred in the presence of tiny amounts of bacterial LPS, but was abolished when this was added together with a two-fold stoichiometric excess of human LBP (lipopolysaccharide binding protein) (<xref ref-type="bibr" rid="c86">Pretorius et al., 2016d</xref>). Recent work in mice lends strong support to the view that the gut microbiome can play a major role in the aetiology of PD (<xref ref-type="bibr" rid="c99">Sampson et al., 2016</xref>).</p>
<p>Iron is also capable of catalysing anomalous blood clotting (<xref ref-type="bibr" rid="c93">Pretorius et al., 2013b</xref>; <xref ref-type="bibr" rid="c82">Pretorius et al., 2014a</xref>), and there are strong indications for both iron dysregulation (<xref ref-type="bibr" rid="c18">Double et al., 2000</xref>; <xref ref-type="bibr" rid="c46">Kaur et al., 2003</xref>; <xref ref-type="bibr" rid="c112">Valko et al., 2005</xref>; <xref ref-type="bibr" rid="c7">Berg et al., 2008</xref>; <xref ref-type="bibr" rid="c47">Kell, 2008</xref>; <xref ref-type="bibr" rid="c49">Kell, 2010</xref>; <xref ref-type="bibr" rid="c24">Friedman and Galazka-Friedman, 2012</xref>; <xref ref-type="bibr" rid="c26">Funke et al., 2013</xref>; <xref ref-type="bibr" rid="c31">Hare et al., 2014</xref>; <xref ref-type="bibr" rid="c54">Kell and Pretorius, 2014</xref>; <xref ref-type="bibr" rid="c70">McDowall and Brown, 2016</xref>) and coagulopathies (<xref ref-type="bibr" rid="c84">Pretorius and Kell, 2014</xref>) in Parkinson&#x2019;s disease. The purpose of the present paper was thus to study whether (the extent of) fibrin-type amyloid in blood varies between suitably matched controls and individuals with Parkinson&#x2019;s disease. In addition, we wished to know whether the removal of any LPS using LBP affected this in any way. It became clear that the answers are in the affirmative in both cases.</p>
</sec>
<sec id="s2">
<title>Materials and Methods</title>
<sec id="s2a">
<title>Ethical statement</title>
<p>Ethical clearance was obtained from the Health Sciences Ethical Committee of the University of Pretoria and informed consent was obtained from each of the patients, as well as from controls (ethical number: 80/2013 and reapproved 2015). Exclusion criteria for the PD were conditions such as asthma, human immunodeficiency virus (HIV) or tuberculosis, and risk factors associated with metabolic syndrome, smoking, and (if female) being on contraceptive or hormone replacement treatment. Exclusion criteria for the healthy population were known inflammatory conditions such as asthma, human immunodeficiency virus (HIV) or tuberculosis, and risk factors associated with metabolic syndrome, smoking, and if female, being on contraceptive or hormone replacement treatment. This population did not take any anti-inflammatory medication. Whole blood of all participants was obtained in citrate tubes and platelet poor plasma (PPP) was used for confocal and SEM experiments. The methods were carried out in accordance with the approved guidelines. Blood was collected and methods were carried out in accordance with the relevant guidelines of the ethics committee. We adhered strictly to the Declaration of Helsinki.</p>
</sec>
<sec id="s2b">
<title>Sample population</title>
<p>In this study, 10 healthy, age-controlled individuals of whom 9 were spouses of some of the Parkinson&#x2019;s disease (PD) individuals, and 26 individuals diagnosed with PD, were included. We also statistically compared results of healthy individuals from a previous study with Exclusion criteria for the healthy population were known inflammatory conditions such as asthma, human immunodeficiency virus (HIV) or tuberculosis, and risk factors associated with metabolic syndrome, smoking, and if female, being on contraceptive or hormone replacement treatment. The PD patients were diagnosed by a Neurologist and the Unified Parkinson&#x2019;s Disease Rating Scale (UPDRS) was used in this diagnoses. On the day of blood collection, the Hoehn and Yahr scale was used by a clinician to rate the relative level of the PD disability (see <xref ref-type="table" rid="tbl1">Table 1</xref> for the stages). Margaret M. Hoehn and Melvin D Yahr developed the Hoehn and Yahr scale to scale practically the severity of PD at the time of treatment, and thereby determine whether the medication or treatment that is used influences the rate of the progression of the disease (<xref ref-type="bibr" rid="c33">Hoehn and Yahr, 1967</xref>). Many studies thereafter have used this method in scaling the severity of movement disorders (<xref ref-type="bibr" rid="c105">Stocchi et al., 1997</xref>; <xref ref-type="bibr" rid="c45">Karlsen et al., 2000</xref>; <xref ref-type="bibr" rid="c101">Schrag et al., 2000a</xref>; <xref ref-type="bibr" rid="c102">b</xref>; <xref ref-type="bibr" rid="c97">Rodr&#x00ED;guez-Violante et al., 2015</xref>).</p>
<table-wrap id="tbl1" orientation="portrait" position="float">
<label>Table 1:</label>
<caption><p>Relative level of disability and stage of Parkinson&#x2019;s disease the Hoehn and Yahr scale.</p></caption>
<graphic xlink:href="124180v1_tbl1.tif"/>
</table-wrap>
</sec>
<sec id="s2c">
<title>LPS-binding protein</title>
<p>A final LPS-binding protein (LBP) exposure concentration of 2 ng.L<sup>-1</sup> LBP was used.</p>
</sec>
<sec id="s2d">
<title>Airyscan and scanning electron microscopy</title>
<p>PPP was prepared from whole blood collected in citrated tubes, from both healthy and PD individuals. For Airyscan preparation, we added Thioflavin T (ThT) at a final concentration of 5 &#x00B5;M to 200 &#x00B5;L of various prepared PPP samples and incubated it (protected from light) for one minute. This step was followed with the addition of thrombin, added in the ratio 1:2 to create extensive fibrin networks. A coverslip was placed over the prepared clot, and viewed immediately with a Zeiss LSM 510 META confocal microscope with a Plan-Apochromat 163 and 100x/1.4 Oil DIC objective. Excitation was at 488 nm and emitted light was measured at 505-550 nm. In addition, PPP from PD individuals were incubated with PBP (final concentration 2 ng. L<sup>-1</sup>) for 10 minutes, followed by ThT and clot preparation as for the healthy and na&#x00EF;ve PD PPP. Clots were also prepared for SEM analysis, but after addition of thrombin, clots were washed, fixed in 4&#x0025; formaldehyde and prepared for SEM according to known SEM preparation methods. Samples were viewed using a Zeiss cross beam electron microscope was used to study fibrin fibres.</p>
</sec>
<sec id="s2e">
<title>Statistical analysis</title>
<p>The non-parametric Mann&#x2013;Whitney U test (between controls and PD samples) and the parametric T-test was performed (within samples) using the STATSDIRECT software.</p>
</sec>
</sec>
<sec id="s3">
<title>Results</title>
<p><xref ref-type="table" rid="tbl2">Table 2</xref> shows demographics for the healthy and the PD groups. The median of the Hoehn and Yahr scale for the PD individuals were 2.5 (&#x00B1;0.43); suggesting that mostly, individuals participating in this study had mild bilateral PD symptoms at date of blood collection. Airyscan results are shown in <xref ref-type="fig" rid="fig1">Figures 1</xref> to <xref ref-type="fig" rid="fig4">4</xref>, for the healthy and PD individuals.</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure"><label>Figure 1:</label>
<caption><p><bold>A and B)</bold> Clot structure from two healthy individuals. All clots were created by adding thrombin to PPP.</p>
</caption>
<graphic xlink:href="124180v1_fig1.tif"/>
</fig>
<table-wrap id="tbl2" orientation="portrait" position="float">
<label>Table 2:</label>
<caption><p>Demographics for the healthy and the PD individuals.</p></caption>
<graphic xlink:href="124180v1_tbl2.tif"/>
</table-wrap>
<sec id="s3a">
<title>Scanning electron microscopy of PPP clots</title>
<p><xref ref-type="fig" rid="fig1">Figure 1</xref> shows how fibrin clots created from healthy PPP, looks like under a 10 000x machine magnification. Fibers have a spaghetti-like appearance, where individual fibres are visible. Fibrin clots created from PPP of PD individuals, all have a typical matted appearance, where individual fibres are entwined into a matted mass (see <xref ref-type="fig" rid="fig2">Figure 2</xref>), indicative of hypercoagulation. We recently suggested that this changed fibrin protein structure in inflammatory conditions like T2D, rheumatoid arthritis and others, are due to &#x03B2;-sheet-rich areas forming in the presence of both upregulated inflammatory markers, and particularly the presence or LPS (<xref ref-type="bibr" rid="c86">Pretorius et al., 2016d</xref>). We also showed that LPS added to healthy PPP created clots that showed hypercoagulation, and that the addition of LBP could reverse this pathological fibrin structure (<xref ref-type="bibr" rid="c86">Pretorius et al., 2016d</xref>). As referred to in the introduction, we also showed that the pathological fibrin structure of T2D could be reversed with the addition of LBP. Therefore, we suggested that LBP protects the fibres from LPS damage by binding to LPS and therefore that LBP could decrease &#x03B2;-sheet-rich areas in T2D plasma.</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure"><label>Figure 2:</label>
<caption><p><bold>A):</bold> Airyscan micrographs of PPP with added thrombin to form extensive fibrin fibres from an individuals with Parkinson&#x2019;s disease (PD); <bold>B)</bold> PPP from the same individual, but exposed to 2ng.L<sup>-1</sup> LPS-binding protein followed by addition of thrombin. Thioflavin T (ThT) (5 &#x00B5;M) was added before thrombin. Micrographs were taken with a Zeiss LSM 510 META confocal microscope with a Plan-Apochromat 63&#x00D7;/1.4 Oil DIC objective. <italic><bold>LBP dramatically reduced the fluorescence seen in samples from patients with PD.</bold></italic> Gain settings were kept the same during all data capturing and not changed for statistical analysis, but brightness and contrast was slightly adjusted for figure preparation. <bold>C)</bold> SEM micrographs of PPP with added thrombin from the same individuals; <bold>D)</bold> PPP from same individual, but exposed to 2ng. L<sup>-1</sup> LPS-binding protein followed by addition of thrombin.</p>
</caption>
<graphic xlink:href="124180v1_fig2.tif"/>
</fig>
<p>Here we also added LBP to PPP from PD individuals. We could show that in all our PD samples, a structural revert to that similar to clots created from healthy PPP, could be obtained. All raw data, including extensive SOPs for SEM are stored on <ext-link xlink:href="https://1drv.ms/f/s!AgoCOmY3bkKHmWY8VijKiQ-8_5RY">https://1drv.ms/f/s!AgoCOmY3bkKHmWY8VijKiQ-8_5RY</ext-link> and on EP&#x2019;s researchgate profile,<ext-link xlink:href="https://www.researchgate.net/profile/Etheresia_Pretorius">https://www.researchgate.net/profile/Etheresia_Pretorius</ext-link>.</p>
</sec>
<sec id="s3b">
<title>Airyscan super-resolution microscopy of clots created from PPP</title>
<p>Previously we have noted that in healthy PPP, in the presence of ThT, little to no fluorescence was present, with only occasional very small patches of fluorescence (<xref ref-type="bibr" rid="c86">Pretorius et al., 2016d</xref>)&#x2019;(<xref ref-type="bibr" rid="c57">Kell and Pretorius, 2016a</xref>). We have also shown that when LPS had been added to healthy PPP, prior to thrombin, fluorescence was greatly enhanced, suggesting increased binding of ThT to &#x03B2;-sheet-rich areas on the fibrin(ogen) (<xref ref-type="bibr" rid="c86">Pretorius et al., 2016d</xref>)&#x2019;(<xref ref-type="bibr" rid="c57">Kell and Pretorius, 2016a</xref>) From these results, we concluded that LPS binding causes the fibrinogen to polymerise into a form with a greatly increased amount of &#x00DF;-sheet (in the presence of thrombin), reflecting amyloid formation. This causes a strong fluorescence observable (when excited ca 440 nm) in the presence of ThT (see e.g. (<xref ref-type="bibr" rid="c11">Biancalana et al., 2009</xref>; <xref ref-type="bibr" rid="c10">Biancalana and Koide, 2010</xref>)). In this paper, we also show &#x03B2;-sheet-rich areas in clots created from PPP of PD individuals (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p>
<p>Both Airyscan and SEM techniques are typically used only as qualitative methods. However, due to the increase fluorescence in clots prepared from PPP of PD, and also the more uniform and matted clot structure shown in SEM analysis of clots prepared from PD PPP, the variance between light and dark pixels are much less than seen in clots prepared from healthy PPP. We therefore propose using the coefficient of variation (CV) as our metric to quantify and discriminate between clots form healthy PPP and clots from PD PPP. We used ImageJ to calculate the mean and standard deviation of the intensity of the pixels in the images of the clot, using the histogram function, followed by the calculation of the coefficient of variation (i.e. SD/mean) of the intensity of the clot structure. <xref ref-type="fig" rid="fig3">Figure 3</xref> shows boxplots of our SEM results and <xref ref-type="fig" rid="fig4">Figure 4A</xref> to <xref ref-type="fig" rid="fig4">D</xref> show examples of representative histograms of the 8-bit intensity for a typical SEM and confocal clot with and without LBP of a patient with PD. Within-sample analysis was done with the paired T-test and between-samples analysis was done using the Mann-Whitney test (See <xref ref-type="table" rid="tbl3">Table 3</xref>). We did not in this paper repeat Airyscan analysis with clots created with healthy PPP</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3:</label>
<caption><p>Boxplots of the distribution of the coefficients of variation in the pixel intensities of the SEM clot images from the different sample classes analysed (median coefficients of variation for each group is in box above plots).</p>
</caption>
<graphic xlink:href="124180v1_fig3.tif"/>
</fig>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure"><label>Figure 4:</label>
<caption><p><bold>A and B)</bold> Representative histograms of the 8-bit intensity for a typical SEM clot from PPP of an individual with Parkinson&#x2019;s disease and after addition of LBP. <bold>C and D)</bold> Representative histograms of the 8-bit intensity for a typical Airyscan clot from PPP of an individual with Parkinson&#x2019;s disease and after addition of LBP.</p>
</caption>
<graphic xlink:href="124180v1_fig4.tif"/>
</fig>
<table-wrap id="tbl3" orientation="portrait" position="float">
<label>Table 3:</label>
<caption><p>Data for Parkinson&#x2019;s disease and healthy individuals showing the coefficients of variation (CV) of the intensity of the pixels in the clot images.</p></caption>
<graphic xlink:href="124180v1_tbl3.tif"/>
</table-wrap>
</sec>
</sec>
<sec id="s4">
<title>Discussion</title>
<p>Although we have observed anomalies in the kinds of fibrin fibres produced in the plasma of patients with various inflammatory diseases (e.g. (<xref ref-type="bibr" rid="c89">Pretorius et al., 2011b</xref>; <xref ref-type="bibr" rid="c91">Pretorius et al., 2011c</xref>; <xref ref-type="bibr" rid="c88">Pretorius et al., 2012</xref>; <xref ref-type="bibr" rid="c93">Pretorius et al., 2013b</xref>; <xref ref-type="bibr" rid="c82">Pretorius et al., 2014a</xref>; <xref ref-type="bibr" rid="c83">Pretorius et al., 2014b</xref>; <xref ref-type="bibr" rid="c56">Kell and Pretorius, 2015b</xref>; <xref ref-type="bibr" rid="c81">Pretorius et al., 2015</xref>; <xref ref-type="bibr" rid="c57">Kell and Pretorius, 2016a</xref>)), this is the first time that we have observed fibrin amyloid in Parkinson&#x2019;s Disease, as assessed by thioflavin T staining and its sensitivity (and that of fibres observed in the SEM) to LBP. While fibrin and &#x03B1;-synuclein can coaggregate (<xref ref-type="bibr" rid="c9">Bhattacharjee and Bhattacharyya, 2014</xref>), it is especially notable that the thrombin-dependence and SEM fibre sizes tell us that the fibres we observe imply that they are essentially all made of fibrin.</p>
<p>Although &#x03B1;-synuclein fibre formation in the substantia nigra is characteristic of PD, it can also occur extracellularly, and its removal may be of therapeutic benefit (<xref ref-type="bibr" rid="c61">Kim et al., 2012</xref>; <xref ref-type="bibr" rid="c74">Park and Kim, 2013</xref>). The production may be driven by intestinal LPS (<xref ref-type="bibr" rid="c60">Kelly et al., 2014</xref>), while gut microbiota-derived short-chain fatty acids may also have a role (<xref ref-type="bibr" rid="c99">Sampson et al., 2016</xref>).</p>
<p>In terms of treatment (<xref ref-type="bibr" rid="c40">Kakkar and Dahiya, 2015</xref>; <xref ref-type="bibr" rid="c42">Kalia et al., 2015</xref>), we have previously discussed the potential role of iron chelators, both to stop the Fenton reaction (<xref ref-type="bibr" rid="c48">Kell, 2009</xref>)&#x2019;(<xref ref-type="bibr" rid="c49">Kell, 2010</xref>) and to inhibit microbial proliferation (e.g. (<xref ref-type="bibr" rid="c53">Kell et al., 2015</xref>; <xref ref-type="bibr" rid="c55">Kell and Pretorius, 2015a</xref>; <xref ref-type="bibr" rid="c78">Potgieter et al., 2015</xref>; <xref ref-type="bibr" rid="c51">Kell and Kenny, 2016a</xref>)), and iron chelators can definitely also inhibit the formation of dense matted deposits (e.g. (<xref ref-type="bibr" rid="c54">Kell and Pretorius, 2014</xref>)&#x2019;(<xref ref-type="bibr" rid="c92">Pretorius et al., 2013a</xref>; <xref ref-type="bibr" rid="c71">Nielsen and Pretorius, 2014</xref>; <xref ref-type="bibr" rid="c82">Pretorius et al., 2014a</xref>; <xref ref-type="bibr" rid="c84">Pretorius and Kell, 2014</xref>; <xref ref-type="bibr" rid="c56">Kell and Pretorius, 2015b</xref>)). It is now clear that treatment options worth exploring also include anticoagulants; as yet, however, the evidence for any effect of heparin is awaited, due to RCTs not having been done (<xref ref-type="bibr" rid="c66">Li et al., 2010</xref>)</p>
</sec>
<sec id="s5">
<title>Concluding remarks</title>
<p>Overall, the remarkable reversal of amyloid fibrin formation by LBP addition to the plasma of Parkinson&#x2019;s disease patients implies strongly that LPS is naturally pre-existing in said plasma. Although almost all the LPS is bound to plasma proteins under normal conditions (<xref ref-type="bibr" rid="c55">Kell and Pretorius, 2015a</xref>), including presumably to fibrinogen, but in concentrations that are consequently hard to determine (<xref ref-type="bibr" rid="c55">Kell and Pretorius, 2015a</xref>), it is known from the effects of adding them exogenously that LBP molecules can inhibit the LPS-induced formation of the amyloid form of fibrin when thrombin is present (<xref ref-type="bibr" rid="c86">Pretorius et al., 2016d</xref>). Consequently, the present work lends strong support to the idea (and evidence (<xref ref-type="bibr" rid="c27">Gabrielli et al., 2011</xref>; <xref ref-type="bibr" rid="c108">Tlaskalov&#x00E1;-Hogenov&#x00E1; et al., 2011</xref>)) that a dormant blood and tissue microbiome is at least part of the aetiology of Parkinson&#x2019;s disease.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>We thank the Biotechnology and Biological Sciences Research Council (grant BB/L025752/1) as well as the National Research Foundation (NRF) of South Africa (91548: Competitive Program) and the Medical Research Council of South Africa (MRC) (Self-Initiated Research Program: A0X331 for supporting this collaboration. The authors thank Dr Prashilla Soma: Clinician. Some reagent funds were supplied as a philanthropic gift by an anonymous donor.</p>
</ack>
<sec id="s6">
<title>Disclosure</title>
<p>The authors (EP, SM, DBK) do not have any conflict of interest to declare.</p>
</sec>
<sec id="s7">
<title>Author contribution statement</title>
<p>EP is the study leader, analysed all samples, prepared all figures, co-wrote paper; SM: technical assistance with SEM preparation; DBK is the study co-leader, and co-wrote and edited the paper. All authors reviewed the manuscript.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="journal"><string-name><surname>Altamura</surname>, <given-names>S.</given-names></string-name>, and <string-name><surname>Muckenthaler</surname>, <given-names>M. U.</given-names></string-name> (<year>2009</year>). <article-title>Iron toxicity in diseases of aging: Alzheimer&#x2019;s disease, Parkinson&#x2019;s disease and atherosclerosis</article-title>. <source>J Alzheimers Dis</source> <volume>16</volume>, <fpage>879</fpage>&#x2013;<lpage>895</lpage>.</mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><string-name><surname>Alzahrani</surname>, <given-names>S. H.</given-names></string-name>, and <string-name><surname>Ajjan</surname>, <given-names>R. A.</given-names></string-name> (<year>2010</year>). <article-title>Coagulation and fibrinolysis in diabetes</article-title>. <source>Diabet Vasc Dis Res</source> <volume>7</volume>, <fpage>260</fpage>&#x2013;<lpage>273</lpage>. doi: <pub-id pub-id-type="doi">10.1177/1479164110383723</pub-id>.</mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><string-name><surname>Alzahrani</surname>, <given-names>S. H.</given-names></string-name>, <string-name><surname>Hess</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Price</surname>, <given-names>J. F.</given-names></string-name>, <string-name><surname>Strachan</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Baxter</surname>, <given-names>P. D.</given-names></string-name>, <string-name><surname>Cubbon</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Phoenix</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Gamlen</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Ari&#x00EB;ns</surname>, <given-names>R. a. S.</given-names></string-name>, <string-name><surname>Grant</surname>, <given-names>P. J.</given-names></string-name>, and <string-name><surname>Ajjan</surname>, <given-names>R. A.</given-names></string-name> (<year>2012</year>). <article-title>Gender-specific alterations in fibrin structure function in type 2 diabetes: associations with cardiometabolic and vascular markers</article-title>. <source>J Clin Endocrinol Metab</source> <volume>97</volume>, <fpage>E2282</fpage>&#x2013;<lpage>2287</lpage>. doi: <pub-id pub-id-type="doi">10.1210/jc.2012-2128</pub-id>.</mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><string-name><surname>Antony</surname>, <given-names>P. M. A.</given-names></string-name>, <string-name><surname>Diederich</surname>, <given-names>N. J.</given-names></string-name>, <string-name><surname>Kr&#x00FC;ger</surname>, <given-names>R.</given-names></string-name>, and <string-name><surname>Balling</surname>, <given-names>R.</given-names></string-name> (<year>2013</year>). <article-title>The hallmarks of Parkinson&#x2019;s disease</article-title>. <source>FEBS J</source> <volume>280</volume>, <fpage>5981</fpage>&#x2013;<lpage>5993</lpage>. doi: <pub-id pub-id-type="doi">10.1111/febs.12335</pub-id>.</mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><string-name><surname>Averett</surname>, <given-names>L. E.</given-names></string-name>, <string-name><surname>Geer</surname>, <given-names>C. B.</given-names></string-name>, <string-name><surname>Fuierer</surname>, <given-names>R. R.</given-names></string-name>, <string-name><surname>Akhremitchev</surname>, <given-names>B. B.</given-names></string-name>, <string-name><surname>Gorkun</surname>, <given-names>O. V.</given-names></string-name>, and <string-name><surname>Schoenfisch</surname>, <given-names>M. H.</given-names></string-name> (<year>2008</year>). <article-title>Complexity of &#x201C;A-a&#x201D; knob-hole fibrin interaction revealed by atomic force spectroscopy</article-title>. <source>Langmuir</source> <volume>24</volume>, <fpage>4979</fpage>&#x2013;<lpage>4988</lpage>. doi: <pub-id pub-id-type="doi">10.1021/la703264x</pub-id>.</mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><string-name><surname>Barnham</surname>, <given-names>K. J.</given-names></string-name>, and <string-name><surname>Bush</surname>, <given-names>A. I.</given-names></string-name> (<year>2008</year>). <article-title>Metals in Alzheimer&#x2019;s and Parkinson&#x2019;s diseases</article-title>. <source>Curr Opin Chem Biol</source> <volume>12</volume>, <fpage>222</fpage>&#x2013;<lpage>228</lpage>.</mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><string-name><surname>Berg</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Riederer</surname>, <given-names>P.</given-names></string-name>, and <string-name><surname>Gerlach</surname>, <given-names>M.</given-names></string-name> (<year>2008</year>). <article-title>Contribution of disturbed iron metabolism to the pathogenesis of Parkinson&#x2019;s disease</article-title>. <source>Future Med</source> <volume>3</volume>, <fpage>447</fpage>&#x2013;<lpage>461</lpage>.</mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><string-name><surname>Bester</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Soma</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name>, and <string-name><surname>Pretorius</surname>, <given-names>E.</given-names></string-name> (<year>2015</year>). <article-title>Viscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS)</article-title>. <source>Oncotarget Gerontology</source> <volume>6</volume>, <fpage>35284</fpage>&#x2013;<lpage>35303</lpage>.</mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="book"><string-name><surname>Bhattacharjee</surname>, <given-names>P.</given-names></string-name>, and <string-name><surname>Bhattacharyya</surname>, <given-names>D.</given-names></string-name> (<year>2014</year>). &#x201C;<chapter-title>An Insight into the Abnormal Fibrin Clots &#x2014; Its Pathophysiological Roles</chapter-title>,&#x201D; in <source>Fibrinolysis and Thrombolysis</source>, ed. <person-group person-group-type="editor"><string-name><given-names>K.</given-names> <surname>Kolev</surname></string-name></person-group>. <publisher-name>InTechOpen</publisher-name>), <fpage>1</fpage>&#x2013;<lpage>29</lpage>.</mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><string-name><surname>Biancalana</surname>, <given-names>M.</given-names></string-name>, and <string-name><surname>Koide</surname>, <given-names>S.</given-names></string-name> (<year>2010</year>). <article-title>Molecular mechanism of Thioflavin-T binding to amyloid fibrils</article-title>. <source>Biochim Biophys Acta</source> <volume>1804</volume>, <fpage>1405</fpage>&#x2013;<lpage>1412</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbapap.2010.04.001</pub-id>.</mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><string-name><surname>Biancalana</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Makabe</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Koide</surname>, <given-names>A.</given-names></string-name>, and <string-name><surname>Koide</surname>, <given-names>S.</given-names></string-name> (<year>2009</year>). <article-title>Molecular mechanism of thioflavin-T binding to the surface of beta-rich peptide self-assemblies</article-title>. <source>J Mol Biol</source> <volume>385</volume>, <fpage>1052</fpage>&#x2013;<lpage>1063</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jmb.2008.11.006</pub-id>.</mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><string-name><surname>Campbell</surname>, <given-names>R. A.</given-names></string-name>, <string-name><surname>Aleman</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Gray</surname>, <given-names>L. D.</given-names></string-name>, <string-name><surname>Falvo</surname>, <given-names>M. R.</given-names></string-name>, and <string-name><surname>Wolberg</surname>, <given-names>A. S.</given-names></string-name> (<year>2010</year>). <article-title>Flow profoundly influences fibrin network structure: implications for fibrin formation and clot stability in haemostasis</article-title>. <source>Thromb Haemost</source> <volume>104</volume>, <fpage>1281</fpage>&#x2013;<lpage>1284</lpage>. doi: <pub-id pub-id-type="doi">10.1160/TH10-07-0442</pub-id>.</mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><string-name><surname>Chiti</surname>, <given-names>F.</given-names></string-name>, and <string-name><surname>Dobson</surname>, <given-names>C. M.</given-names></string-name> (<year>2006</year>). <article-title>Protein misfolding, functional amyloid, and human disease</article-title>. <source>Annu Rev Biochem</source> <volume>75</volume>, <fpage>333</fpage>&#x2013;<lpage>366</lpage>.</mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><string-name><surname>Cilia La Corte</surname>, <given-names>A. L.</given-names></string-name>, <string-name><surname>Philippou</surname>, <given-names>H.</given-names></string-name>, and <string-name><surname>Ari&#x00EB;ns</surname>, <given-names>R. a. S.</given-names></string-name> (<year>2011</year>). <article-title>Role of fibrin structure in thrombosis and vascular disease</article-title>. <source>Adv Protein Chem Struct Biol</source> <volume>83</volume>, <fpage>75</fpage>&#x2013;<lpage>127</lpage>. doi: <pub-id pub-id-type="doi">10.1016/B978-0-12-381262-9.00003-3</pub-id>.</mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><string-name><surname>Dickneite</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Herwald</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Korte</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Allanore</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Denton</surname>, <given-names>C. P.</given-names></string-name>, and <string-name><surname>Matucci Cerinic</surname>, <given-names>M.</given-names></string-name> (<year>2015</year>). <article-title>Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions</article-title>. <source>Thromb Haemost</source> <volume>113</volume>, <fpage>686</fpage>&#x2013;<lpage>697</lpage>. doi: <pub-id pub-id-type="doi">10.1160/TH14-07-0625</pub-id>.</mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><string-name><surname>Domingue</surname>, <given-names>G. J.</given-names></string-name> (<year>2010</year>). <article-title>Demystifying pleomorphic forms in persistence and expression of disease: Are they bacteria, and is peptidoglycan the solution?</article-title> <source>Discov Med</source> <volume>10</volume>, <fpage>234</fpage>&#x2013;<lpage>246</lpage>.</mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><string-name><surname>Domingue</surname>, <given-names>G. J.</given-names></string-name>, and <string-name><surname>Woody</surname>, <given-names>H. B.</given-names></string-name> (<year>1997</year>). <article-title>Bacterial persistence and expression of disease</article-title>. <source>Clin Microbiol Rev</source> <volume>10</volume>, <fpage>320</fpage>&#x2013;<lpage>344</lpage>.</mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><string-name><surname>Double</surname>, <given-names>K. L.</given-names></string-name>, <string-name><surname>Gerlach</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Youdim</surname>, <given-names>M. B.</given-names></string-name>, and <string-name><surname>Riederer</surname>, <given-names>P.</given-names></string-name> (<year>2000</year>). <article-title>Impaired iron homeostasis in Parkinson&#x2019;s disease</article-title>. <source>J Neural Transm Suppl</source>, <fpage>37</fpage>&#x2013;<lpage>58</lpage>.</mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="journal"><string-name><surname>Dunn</surname>, <given-names>E. J.</given-names></string-name>, and <string-name><surname>Ari&#x00EB;ns</surname>, <given-names>R. a. S.</given-names></string-name> (<year>2004</year>). <article-title>Fibrinogen and fibrin clot structure in diabetes</article-title>. <source>Herz</source> <volume>29</volume>, <fpage>470</fpage>&#x2013;<lpage>479</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00059-004-2607-z</pub-id>.</mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><string-name><surname>Dunn</surname>, <given-names>E. J.</given-names></string-name>, <string-name><surname>Ari&#x00EB;ns</surname>, <given-names>R. a. S.</given-names></string-name>, and <string-name><surname>Grant</surname>, <given-names>P. J.</given-names></string-name> (<year>2005</year>). <article-title>The influence of type 2 diabetes on fibrin structure and function</article-title>. <source>Diabetologia</source> <volume>48</volume>, <fpage>1198</fpage>&#x2013;<lpage>1206</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00125-005-1742-2</pub-id>.</mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><string-name><surname>Dunn</surname>, <given-names>E. J.</given-names></string-name>, <string-name><surname>Philippou</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Ari&#x00EB;ns</surname>, <given-names>R. a. S.</given-names></string-name>, and <string-name><surname>Grant</surname>, <given-names>P. J.</given-names></string-name> (<year>2006</year>). <article-title>Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus</article-title>. <source>Diabetologia</source> <volume>49</volume>, <fpage>1071</fpage>&#x2013;<lpage>1080</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00125-006-0197-4</pub-id>.</mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><string-name><surname>Eisenberg</surname>, <given-names>D.</given-names></string-name>, and <string-name><surname>Jucker</surname>, <given-names>M.</given-names></string-name> (<year>2012</year>). <article-title>The amyloid state of proteins in human diseases</article-title>. <source>Cell</source> <volume>148</volume>, <fpage>1188</fpage>&#x2013;<lpage>1203</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2012.02.022</pub-id>.</mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><string-name><surname>Freire</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>De Araujo</surname>, <given-names>M. H.</given-names></string-name>, <string-name><surname>Al-Soufi</surname>, <given-names>W.</given-names></string-name>, and <string-name><surname>Novo</surname>, <given-names>M.</given-names></string-name> (<year>2014</year>). <article-title>Photophysical study of Thioflavin T as fluorescence marker of amyloid fibrils</article-title>. <source>Dyes and Pigments</source> <volume>110</volume>, <fpage>97</fpage>&#x2013;<lpage>105</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.dyepig.2014.05.004</pub-id>.</mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><string-name><surname>Friedman</surname>, <given-names>A.</given-names></string-name>, and <string-name><surname>Galazka-Friedman</surname>, <given-names>J.</given-names></string-name> (<year>2012</year>). <article-title>The history of the research of iron in parkinsonian substantia nigra</article-title>. <source>J Neural Transm</source> <volume>119</volume>, <fpage>1507</fpage>&#x2013;<lpage>1510</lpage>.</mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="journal"><string-name><surname>Fujita</surname>, <given-names>K. A.</given-names></string-name>, <string-name><surname>Ostaszewski</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Matsuoka</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Ghosh</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Glaab</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Trefois</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Crespo</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Perumal</surname>, <given-names>T. M.</given-names></string-name>, <string-name><surname>Jurkowski</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Antony</surname>, <given-names>P. M.</given-names></string-name>, <string-name><surname>Diederich</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Buttini</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kodama</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Satagopam</surname>, <given-names>V. P.</given-names></string-name>, <string-name><surname>Eifes</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Del Sol</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Schneider</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Kitano</surname>, <given-names>H.</given-names></string-name>, and <string-name><surname>Balling</surname>, <given-names>R.</given-names></string-name> (<year>2014</year>). <article-title>Integrating pathways of Parkinson&#x2019;s disease in a molecular interaction map</article-title>. <source>Mol Neurobiol</source> <volume>49</volume>, <fpage>88</fpage>&#x2013;<lpage>102</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12035-013-8489-4</pub-id>.</mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><string-name><surname>Funke</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Schneider</surname>, <given-names>S. A.</given-names></string-name>, <string-name><surname>Berg</surname>, <given-names>D.</given-names></string-name>, and <string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name> (<year>2013</year>). <article-title>Genetics and iron in the systems biology of Parkinson&#x2019;s disease and some related disorders</article-title>. <source>Neurochem Internat</source> <volume>62</volume>, <fpage>637</fpage>&#x2013;<lpage>652</lpage>.</mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><string-name><surname>Gabrielli</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Bonazzi</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Scarpellini</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Bendia</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Lauritano</surname>, <given-names>E. C.</given-names></string-name>, <string-name><surname>Fasano</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Ceravolo</surname>, <given-names>M. G.</given-names></string-name>, <string-name><surname>Capecci</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Rita Bentivoglio</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Provinciali</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Tonali</surname>, <given-names>P. A.</given-names></string-name>, and <string-name><surname>Gasbarrini</surname>, <given-names>A.</given-names></string-name> (<year>2011</year>). <article-title>Prevalence of small intestinal bacterial overgrowth in Parkinson&#x2019;s disease</article-title>. <source>Mov Disord</source> <volume>26</volume>, <fpage>889</fpage>&#x2013;<lpage>892</lpage>. doi: <pub-id pub-id-type="doi">10.1002/mds.23566</pub-id>.</mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><string-name><surname>Gerlach</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Riederer</surname>, <given-names>P.</given-names></string-name>, and <string-name><surname>Double</surname>, <given-names>K. L.</given-names></string-name> (<year>2008</year>). <article-title>Neuromelanin-bound ferric iron as an experimental model of dopaminergic neurodegeneration in Parkinson&#x2019;s disease</article-title>. <source>Parkinsonism Relat Disord</source> <volume>14</volume> <issue>Suppl 2</issue>, <fpage>S185</fpage>&#x2013;<lpage>188</lpage>.</mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><string-name><surname>Groenning</surname>, <given-names>M.</given-names></string-name> (<year>2010</year>). <article-title>Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils-current status</article-title>. <source>J Chem Biol</source> <volume>3</volume>, <fpage>1</fpage>&#x2013;<lpage>18</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12154-009-0027-5</pub-id>.</mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="journal"><string-name><surname>Haidinger</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Werzowa</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Kain</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Antlanger</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Hecking</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Pfaffenberger</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Mascherbauer</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Gremmel</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Gilbertson</surname>, <given-names>J. A.</given-names></string-name>, <string-name><surname>Rowczenio</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Weichhart</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Kopecky</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>H&#x00F6;rl</surname>, <given-names>W. H.</given-names></string-name>, <string-name><surname>Hawkins</surname>, <given-names>P. N.</given-names></string-name>, and <string-name><surname>S&#x00E4;emann</surname>, <given-names>M. D.</given-names></string-name> (<year>2013</year>). <article-title>Hereditary amyloidosis caused by R554L fibrinogen Aalpha-chain mutation in a Spanish family and review of the literature</article-title>. <source>Amyloid</source> <volume>20</volume>, <fpage>72</fpage>&#x2013;<lpage>79</lpage>. doi: <pub-id pub-id-type="doi">10.3109/13506129.2013.781998</pub-id>.</mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="other"><string-name><surname>Hare</surname>, <given-names>D. J.</given-names></string-name>, <string-name><surname>Lei</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Ayton</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Roberts</surname>, <given-names>B. R.</given-names></string-name>, <string-name><surname>Grimm</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>George</surname>, <given-names>J. L.</given-names></string-name>, <string-name><surname>Bishop</surname>, <given-names>D. P.</given-names></string-name>, <string-name><surname>Beavis</surname>, <given-names>A. D.</given-names></string-name>, <string-name><surname>Donovan</surname>, <given-names>S. J.</given-names></string-name>, <string-name><surname>Mccoll</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Volitakis</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Masters</surname>, <given-names>C. L.</given-names></string-name>, <string-name><surname>Adlard</surname>, <given-names>P. A.</given-names></string-name>, <string-name><surname>Cherny</surname>, <given-names>R. A.</given-names></string-name>, <string-name><surname>Bush</surname>, <given-names>A. I.</given-names></string-name>, <string-name><surname>Finkelstein</surname>, <given-names>D. I.</given-names></string-name>, and <string-name><surname>Doble</surname>, <given-names>P. A.</given-names></string-name> (<year>2014</year>). <article-title>An iron&#x2013;dopamine index predicts risk of parkinsonian neurodegeneration in the substantia nigra pars compacta</article-title>. <source>Chem Sci</source>, DOI: <pub-id pub-id-type="doi">10.1039/c1033sc53461h</pub-id>.</mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><string-name><surname>Herczenik</surname>, <given-names>E.</given-names></string-name>, and <string-name><surname>Gebbink</surname>, <given-names>M. F. B. G.</given-names></string-name> (<year>2008</year>). <article-title>Molecular and cellular aspects of protein misfolding and disease</article-title>. <source>FASEB J</source> <volume>22</volume>, <fpage>2115</fpage>&#x2013;<lpage>2133</lpage>. doi: <pub-id pub-id-type="doi">10.1096/fj.07-099671</pub-id>.</mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><string-name><surname>Hoehn</surname>, <given-names>M. M.</given-names></string-name>, and <string-name><surname>Yahr</surname>, <given-names>M. D.</given-names></string-name> (<year>1967</year>). <article-title>Parkinsonism: onset, progression and mortality</article-title>. <source>Neurology</source> <volume>17</volume>, <fpage>427</fpage>&#x2013;<lpage>442</lpage>.</mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><string-name><surname>Infante</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Prieto</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Sierra</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>S&#x00E1;nchez-Juan</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Gonz&#x00E1;lez-Aramburu</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Sanchez-Quintana</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Berciano</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Combarros</surname>, <given-names>O.</given-names></string-name>, and <string-name><surname>Sainz</surname>, <given-names>J.</given-names></string-name> (<year>2016</year>). <article-title>Comparative blood transcriptome analysis in idiopathic and LRRK2 G2019S-associated Parkinson&#x2019;s disease</article-title>. <source>Neurobiol Aging</source> <volume>38</volume>, <issue>214</issue> <fpage>e211</fpage>&#x2013;<lpage>215</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2015.10.026</pub-id>.</mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><string-name><surname>Itzhaki</surname>, <given-names>R. F.</given-names></string-name>, <string-name><surname>Lathe</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Balin</surname>, <given-names>B. J.</given-names></string-name>, <string-name><surname>Ball</surname>, <given-names>M. J.</given-names></string-name>, <string-name><surname>Braak</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Bearer</surname>, <given-names>E. L.</given-names></string-name>, <string-name><surname>Bullido</surname>, <given-names>M. J.</given-names></string-name>, <string-name><surname>Carter</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Clerici</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Cosby</surname>, <given-names>S. L.</given-names></string-name>, <string-name><surname>Del Tredici</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Field</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Fulop</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Grassi</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Griffin</surname>, <given-names>W. S. T.</given-names></string-name>, <string-name><surname>Haas</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Hudson</surname>, <given-names>A. P.</given-names></string-name>, <string-name><surname>Kamer</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name>, <string-name><surname>Licastro</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Letenneur</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>L&#x00F6;vheim</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Mancuso</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Miklossy</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Otth</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Palamara</surname>, <given-names>A. T.</given-names></string-name>, <string-name><surname>Perry</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Preston</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Pretorius</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Strandberg</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Tabet</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Taylor-Robinson</surname>, <given-names>S. D.</given-names></string-name>, and <string-name><surname>Whittum-Hudson</surname>, <given-names>J. A.</given-names></string-name> (<year>2016</year>). <article-title>Microbes and Alzheimer&#x2019;s Disease</article-title>. <source>J Alzheimers Dis</source> <volume>51</volume>, <fpage>979</fpage>&#x2013;<lpage>984</lpage>. doi: <pub-id pub-id-type="doi">10.3233/JAD-160152</pub-id>.</mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><string-name><surname>Jameson</surname>, <given-names>G. N. L.</given-names></string-name> (<year>2011</year>). <article-title>Iron, cysteine and Parkinson&#x2019;s disease</article-title>. <source>Monatshefte Fur Chemie</source> <volume>142</volume>, <fpage>325</fpage>&#x2013;<lpage>329</lpage>.</mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><string-name><surname>Jones</surname>, <given-names>B. C.</given-names></string-name>, <string-name><surname>Beard</surname>, <given-names>J. L.</given-names></string-name>, <string-name><surname>Gibson</surname>, <given-names>J. N.</given-names></string-name>, <string-name><surname>Unger</surname>, <given-names>E. L.</given-names></string-name>, <string-name><surname>Allen</surname>, <given-names>R. P.</given-names></string-name>, <string-name><surname>Mccarthy</surname>, <given-names>K. A.</given-names></string-name>, and <string-name><surname>Earley</surname>, <given-names>C. J.</given-names></string-name> (<year>2007</year>). <article-title>Systems genetic analysis of peripheral iron parameters in the mouse</article-title>. <source>Am J Physiol Regul Integr Comp Physiol</source> <volume>293</volume>, <fpage>R116</fpage>&#x2013;<lpage>124</lpage>.</mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><string-name><surname>Jones</surname>, <given-names>B. C.</given-names></string-name>, <string-name><surname>Miller</surname>, <given-names>D. B.</given-names></string-name>, <string-name><surname>O&#x2019;callaghan</surname>, <given-names>J. P.</given-names></string-name>, <string-name><surname>Lu</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Unger</surname>, <given-names>E. L.</given-names></string-name>, <string-name><surname>Alam</surname>, <given-names>G.</given-names></string-name>, and <string-name><surname>Williams</surname>, <given-names>R. W.</given-names></string-name> (<year>2013</year>). <article-title>Systems analysis of genetic variation in MPTP neurotoxicity in mice</article-title>. <source>Neurotoxicology</source> <volume>37C</volume>, <fpage>26</fpage>&#x2013;<lpage>34</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuro.2013.03.010</pub-id>.</mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><string-name><surname>J&#x00F6;rneskog</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Egberg</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Fagrell</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Fatah</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Hessel</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Johnsson</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Brismar</surname>, <given-names>K.</given-names></string-name>, and <string-name><surname>Blomb&#x00E4;ck</surname>, <given-names>M.</given-names></string-name> (<year>1996</year>). <article-title>Altered properties of the fibrin gel structure in patients with IDDM</article-title>. <source>Diabetologia</source> <volume>39</volume>, <fpage>1519</fpage>&#x2013;<lpage>1523</lpage>.</mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="journal"><string-name><surname>Kakkar</surname>, <given-names>A.K.</given-names></string-name>, and <string-name><surname>Dahiya</surname>, <given-names>N.</given-names></string-name> (<year>2015</year>). <article-title>Management of Parkinsons disease: Current and future pharmacotherapy</article-title>. <source>Eur J Pharmacol</source> <volume>750</volume>, <fpage>74</fpage>&#x2013;<lpage>81</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ejphar.2015.01.030</pub-id>.</mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><string-name><surname>Kalia</surname>, <given-names>L. V.</given-names></string-name>, and <string-name><surname>Kalia</surname>, <given-names>S. K.</given-names></string-name> (<year>2015</year>). <article-title>alpha-Synuclein and Lewy pathology in Parkinson&#x2019;s disease</article-title>. <source>Curr Opin Neurol</source> <volume>28</volume>, <fpage>375</fpage>&#x2013;<lpage>381</lpage>. doi: <pub-id pub-id-type="doi">10.1097/WCO.0000000000000215</pub-id>.</mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><string-name><surname>Kalia</surname>, <given-names>L. V.</given-names></string-name>, <string-name><surname>Kalia</surname>, <given-names>S. K.</given-names></string-name>, and <string-name><surname>Lang</surname>, <given-names>A. E.</given-names></string-name> (<year>2015</year>). <article-title>Disease-modifying strategies for Parkinson&#x2019;s disease</article-title>. <source>Mov Disord</source> <volume>30</volume>, <fpage>1442</fpage>&#x2013;<lpage>1450</lpage>. doi: <pub-id pub-id-type="doi">10.1002/mds.26354</pub-id>.</mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><string-name><surname>Kalia</surname>, <given-names>L. V.</given-names></string-name>, and <string-name><surname>Lang</surname>, <given-names>A. E.</given-names></string-name> (<year>2015</year>). <article-title>Parkinson&#x2019;s disease</article-title>. <source>Lancet</source> <volume>386</volume>, <fpage>896</fpage>&#x2013;<lpage>912</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(14)61393-3</pub-id>.</mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><string-name><surname>Kaprelyants</surname>, <given-names>A. S.</given-names></string-name>, <string-name><surname>Gottschal</surname>, <given-names>J. C.</given-names></string-name>, and <string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name> (<year>1993</year>). <article-title>Dormancy in non-sporulating bacteria</article-title>. <source>FEMS Microbiol. Rev</source>. <volume>10</volume>, <fpage>271</fpage>&#x2013;<lpage>286</lpage>.</mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="journal"><string-name><surname>Karlsen</surname>, <given-names>K. H.</given-names></string-name>, <string-name><surname>Tandberg</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Arsland</surname>, <given-names>D.</given-names></string-name>, and <string-name><surname>Larsen</surname>, <given-names>J. P.</given-names></string-name> (<year>2000</year>). <article-title>Health related quality of life in Parkinson&#x2019;s disease: a prospective longitudinal study</article-title>. <source>J Neurol Neurosurg Psychiatry</source> <volume>69</volume>, <fpage>584</fpage>&#x2013;<lpage>589</lpage>.</mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><string-name><surname>Kaur</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Yantiri</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Rajagopalan</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Kumar</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Mo</surname>, <given-names>J. O.</given-names></string-name>, <string-name><surname>Boonplueang</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Viswanath</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Jacobs</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Yang</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Beal</surname>, <given-names>M. F.</given-names></string-name>, <string-name><surname>Dimonte</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Volitaskis</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Ellerby</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Cherny</surname>, <given-names>R. A.</given-names></string-name>, <string-name><surname>Bush</surname>, <given-names>A. I.</given-names></string-name>, and <string-name><surname>Andersen</surname>, <given-names>J. K.</given-names></string-name> (<year>2003</year>). <article-title>Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: A novel therapy for Parkinson&#x2019;s disease</article-title>. <source>Neuron</source> <volume>37</volume>, <fpage>899</fpage>&#x2013;<lpage>909</lpage>.</mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="website"><string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name> (<year>2008</year>). <article-title>Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases</article-title>. <ext-link ext-link-type="uri" xlink:href="http://arxiv.org/ftp/arxiv/papers/0808/0808.1371.pdf">http://arxiv.org/ftp/arxiv/papers/0808/0808.1371.pdf</ext-link>.</mixed-citation></ref>
<ref id="c48"><mixed-citation publication-type="journal"><string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name> (<year>2009</year>). <article-title>Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases</article-title>. <source>BMC Med Genom</source> <volume>2</volume>, <fpage>2</fpage></mixed-citation></ref>
<ref id="c49"><mixed-citation publication-type="journal"><string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name> (<year>2010</year>). <article-title>Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson&#x2019;s, Huntington&#x2019;s, Alzheimer&#x2019;s, prions, bactericides, chemical toxicology and others as examples</article-title>. <source>Arch Toxicol</source> <volume>577</volume>, <fpage>825</fpage>&#x2013;<lpage>889</lpage>.</mixed-citation></ref>
<ref id="c50"><mixed-citation publication-type="journal"><string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name>, <string-name><surname>Kaprelyants</surname>, <given-names>A. S.</given-names></string-name>, <string-name><surname>Weichart</surname>, <given-names>D. H.</given-names></string-name>, <string-name><surname>Harwood</surname>, <given-names>C. L.</given-names></string-name>, and <string-name><surname>Barer</surname>, <given-names>M. R.</given-names></string-name> (<year>1998</year>). <article-title>Viability and activity in readily culturable bacteria: a review and discussion of the practical issues</article-title>. <source>Antonie van Leeuwenhoek</source> <volume>73</volume>, <fpage>169</fpage>&#x2013;<lpage>187</lpage>.</mixed-citation></ref>
<ref id="c51"><mixed-citation publication-type="journal"><string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name>, and <string-name><surname>Kenny</surname>, <given-names>L. C.</given-names></string-name> (<year>2016a</year>). <article-title>A dormant microbial component in the development of pre-eclampsia</article-title>. <source>Front Med Obs Gynecol</source> <volume>3</volume>, <fpage>60</fpage>. doi: doi: <pub-id pub-id-type="doi">10.3389/fmed.2016.00060</pub-id></mixed-citation></ref>
<ref id="c52"><mixed-citation publication-type="other"><string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name>, and <string-name><surname>Kenny</surname>, <given-names>L. C.</given-names></string-name> (<year>2016b</year>). <article-title>A dormant microbial component in the development of pre-eclampsia. BioRxiv preprint</article-title>. <source>bioRxiv</source>, <fpage>057356</fpage>.</mixed-citation></ref>
<ref id="c53"><mixed-citation publication-type="journal"><string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name>, <string-name><surname>Potgieter</surname>, <given-names>M.</given-names></string-name>, and <string-name><surname>Pretorius</surname>, <given-names>E.</given-names></string-name> (<year>2015</year>). <article-title>Individuality, phenotypic differentiation, dormancy and &#x2018;persistence&#x2019; in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology</article-title>. <source>F1000Research</source> <volume>4</volume>, <fpage>179</fpage>. doi: DOI: <pub-id pub-id-type="doi">10.12688/f1000research.6709.1</pub-id>.</mixed-citation></ref>
<ref id="c54"><mixed-citation publication-type="journal"><string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name>, and <string-name><surname>Pretorius</surname>, <given-names>E.</given-names></string-name> (<year>2014</year>). <article-title>Serum ferritin is an important disease marker, and is mainly a leakage product from damaged cells</article-title>. <source>Metallomics</source> <volume>6</volume>, <fpage>748</fpage>&#x2013;<lpage>773</lpage>. doi: DOI: <pub-id pub-id-type="doi">10.1039/C3MT00347G</pub-id></mixed-citation></ref>
<ref id="c55"><mixed-citation publication-type="journal"><string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name>, and <string-name><surname>Pretorius</surname>, <given-names>E.</given-names></string-name> (<year>2015a</year>). <article-title>On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: the central roles of LPS and LPS-induced cell death</article-title> <source>Integr Biol</source> <volume>7</volume>, <fpage>1339</fpage>&#x2013;<lpage>1377</lpage>. doi: DOI: <pub-id pub-id-type="doi">10.1039/C5IB00158G</pub-id>.</mixed-citation></ref>
<ref id="c56"><mixed-citation publication-type="journal"><string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name>, and <string-name><surname>Pretorius</surname>, <given-names>E.</given-names></string-name> (<year>2015b</year>). <article-title>The simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen)</article-title>. <source>Integr Biol</source> <volume>7</volume>, <fpage>24</fpage>&#x2013;<lpage>52</lpage>. doi: <pub-id pub-id-type="doi">10.1039/c4ib00173g</pub-id>.</mixed-citation></ref>
<ref id="c57"><mixed-citation publication-type="website"><string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name>, and <string-name><surname>Pretorius</surname>, <given-names>E.</given-names></string-name> (<year>2016a</year>). <article-title>Proteins behaving badly. Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: lessons from and for blood clotting</article-title>. <source>Progr Biophys Mol Biol</source>, online; DOI <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.pbiomolbio.2016.1008.1006">http://dx.doi.org/10.1016/j.pbiomolbio.2016.1008.1006</ext-link>.</mixed-citation></ref>
<ref id="c58"><mixed-citation publication-type="website"><string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name>, and <string-name><surname>Pretorius</surname>, <given-names>E.</given-names></string-name> (<year>2016b</year>). <article-title>Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: lessons from and for blood clotting. bioRxiv preprint</article-title>. <source>bioRxiv</source>, <fpage>054734</fpage>. doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1101/054734">http://dx.doi.org/10.1101/054734</ext-link>.</mixed-citation></ref>
<ref id="c59"><mixed-citation publication-type="website"><string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name>, and <string-name><surname>Pretorius</surname>, <given-names>E.</given-names></string-name> (<year>2016c</year>). <article-title>To what extent are the terminal stages of sepsis, septic shock, SIRS, and multiple organ dysfunction syndrome actually driven by a toxic prion/amyloid form of fibrin? bioRxiv preprint</article-title>. <source>bioRxiv</source>, <fpage>057851</fpage>. doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1101/057851">http://dx.doi.org/10.1101/057851</ext-link>.</mixed-citation></ref>
<ref id="c60"><mixed-citation publication-type="journal"><string-name><surname>Kelly</surname>, <given-names>L. P.</given-names></string-name>, <string-name><surname>Carvey</surname>, <given-names>P. M.</given-names></string-name>, <string-name><surname>Keshavarzian</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Shannon</surname>, <given-names>K. M.</given-names></string-name>, <string-name><surname>Shaikh</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Bakay</surname>, <given-names>R. A.</given-names></string-name>, and <string-name><surname>Kordower</surname>, <given-names>J. H.</given-names></string-name> (<year>2014</year>). <article-title>Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson&#x2019;s disease</article-title>. <source>Mov Disord</source> <volume>29</volume>, <fpage>999</fpage>&#x2013;<lpage>1009</lpage>. doi: <pub-id pub-id-type="doi">10.1002/mds.25736</pub-id>.</mixed-citation></ref>
<ref id="c61"><mixed-citation publication-type="journal"><string-name><surname>Kim</surname>, <given-names>K. S.</given-names></string-name>, <string-name><surname>Choi</surname>, <given-names>Y. R.</given-names></string-name>, <string-name><surname>Park</surname>, <given-names>J. Y.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>J. H.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>D. K.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>S. J.</given-names></string-name>, <string-name><surname>Paik</surname>, <given-names>S. R.</given-names></string-name>, <string-name><surname>Jou</surname>, <given-names>I.</given-names></string-name>, and <string-name><surname>Park</surname>, <given-names>S. M.</given-names></string-name> (<year>2012</year>). <article-title>Proteolytic cleavage of extracellular alpha-synuclein by plasmin: implications for Parkinson disease</article-title>. <source>J Biol Chem</source> <volume>287</volume>, <fpage>24862</fpage>&#x2013;<lpage>24872</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M112.348128</pub-id>.</mixed-citation></ref>
<ref id="c62"><mixed-citation publication-type="journal"><string-name><surname>Knowles</surname>, <given-names>T. P. J.</given-names></string-name>, <string-name><surname>Vendruscolo</surname>, <given-names>M.</given-names></string-name>, and <string-name><surname>Dobson</surname>, <given-names>C. M.</given-names></string-name> (<year>2014</year>). <article-title>The amyloid state and its association with protein misfolding diseases</article-title>. <source>Nat Rev Mol Cell Biol</source> <volume>15</volume>, <fpage>384</fpage>&#x2013;<lpage>396</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrm3810</pub-id>.</mixed-citation></ref>
<ref id="c63"><mixed-citation publication-type="journal"><string-name><surname>Krishna</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Biryukov</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Trefois</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Antony</surname>, <given-names>P. M.</given-names></string-name>, <string-name><surname>Hussong</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Heinaniemi</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Glusman</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Koglsberger</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Boyd</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Van Den Berg</surname>, <given-names>B. H.</given-names></string-name>, <string-name><surname>Linke</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Hood</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Tholey</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Schneider</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Galas</surname>, <given-names>D. J.</given-names></string-name>, <string-name><surname>Balling</surname>, <given-names>R.</given-names></string-name>, and <string-name><surname>May</surname>, <given-names>P.</given-names></string-name> (<year>2014</year>). <article-title>Systems genomics evaluation of the SH-SY5Y neuroblastoma cell line as a model for Parkinson&#x2019;s disease</article-title>. <source>BMC Genomics</source> <volume>15</volume>, <fpage>1154</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1471-2164-15-1154</pub-id>.</mixed-citation></ref>
<ref id="c64"><mixed-citation publication-type="journal"><string-name><surname>Levenson</surname>, <given-names>C. W.</given-names></string-name> (<year>2003</year>). <article-title>Iron and Parkinson&#x2019;s disease: chelators to the rescue?</article-title> <source>Nutr Rev</source> <volume>61</volume>, <fpage>311</fpage>&#x2013;<lpage>313</lpage>.</mixed-citation></ref>
<ref id="c65"><mixed-citation publication-type="journal"><string-name><surname>Levine</surname>, <given-names>H.</given-names>, <suffix>3rd</suffix></string-name> (<year>1999</year>). <article-title>Quantification of beta-sheet amyloid fibril structures with thioflavin T</article-title>. <source>Methods Enzymol</source> <volume>309</volume>, <fpage>274</fpage>&#x2013;<lpage>284</lpage>.</mixed-citation></ref>
<ref id="c66"><mixed-citation publication-type="journal"><string-name><surname>Li</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>H. M.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Zhu</surname>, <given-names>B.</given-names></string-name>, and <string-name><surname>Dong</surname>, <given-names>B. R.</given-names></string-name> (<year>2010</year>). <article-title>Heparin and related substances for preventing diabetic kidney disease</article-title>. <source>Cochrane Database Syst Rev</source>, <fpage>CD005631</fpage>. doi: <pub-id pub-id-type="doi">10.1002/14651858.CD005631.pub2</pub-id>.</mixed-citation></ref>
<ref id="c67"><mixed-citation publication-type="journal"><string-name><surname>Litvinov</surname>, <given-names>R. I.</given-names></string-name>, <string-name><surname>Faizullin</surname>, <given-names>D. A.</given-names></string-name>, <string-name><surname>Zuev</surname>, <given-names>Y. F.</given-names></string-name>, and <string-name><surname>Weisel</surname>, <given-names>J. W.</given-names></string-name> (<year>2012</year>). <article-title>The alpha-helix to beta-sheet transition in stretched and compressed hydrated fibrin clots</article-title>. <source>Biophys J</source> <volume>103</volume>, <fpage>1020</fpage>&#x2013;<lpage>1027</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bpj.2012.07.046</pub-id>.</mixed-citation></ref>
<ref id="c68"><mixed-citation publication-type="journal"><string-name><surname>Maji</surname>, <given-names>S. K.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Greenwald</surname>, <given-names>J.</given-names></string-name>, and <string-name><surname>Riek</surname>, <given-names>R.</given-names></string-name> (<year>2009</year>). <article-title>Structure-activity relationship of amyloid fibrils</article-title>. <source>FEBS Lett</source> <volume>583</volume>, <fpage>2610</fpage>&#x2013;<lpage>2617</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.febslet.2009.07.003</pub-id>.</mixed-citation></ref>
<ref id="c69"><mixed-citation publication-type="book"><string-name><surname>Mattman</surname>, <given-names>L.</given-names></string-name> (<year>2001</year>). <source>Cell wall deficient forms: stealth pathogens</source>, <edition>3rd Ed</edition>. <publisher-loc>Boca Raton</publisher-loc>: <publisher-name>CRC Press</publisher-name>.</mixed-citation></ref>
<ref id="c70"><mixed-citation publication-type="journal"><string-name><surname>Mcdowall</surname>, <given-names>J. S.</given-names></string-name>, and <string-name><surname>Brown</surname>, <given-names>D. R.</given-names></string-name> (<year>2016</year>). <article-title>Alpha-synuclein: relating metals to structure, function and inhibition</article-title>. <source>Metallomics</source> <volume>8</volume>, <fpage>385</fpage>&#x2013;<lpage>397</lpage>. doi: <pub-id pub-id-type="doi">10.1039/c6mt00026f</pub-id>.</mixed-citation></ref>
<ref id="c71"><mixed-citation publication-type="journal"><string-name><surname>Nielsen</surname>, <given-names>V. G.</given-names></string-name>, and <string-name><surname>Pretorius</surname>, <given-names>E.</given-names></string-name> (<year>2014</year>). <article-title>Iron-enhanced coagulation is attenuated by chelation: thrombelastographic and ultrastructural analysis</article-title>. <source>Blood Coagul Fibrinolysis</source> <volume>25</volume>, <fpage>845</fpage>&#x2013;<lpage>850</lpage>. doi: <pub-id pub-id-type="doi">10.1097/MBC.0000000000000160</pub-id>.</mixed-citation></ref>
<ref id="c72"><mixed-citation publication-type="journal"><string-name><surname>Olanow</surname>, <given-names>C. W.</given-names></string-name>, and <string-name><surname>Brundin</surname>, <given-names>P.</given-names></string-name> (<year>2013</year>). <article-title>Parkinson&#x2019;s disease and alpha synuclein: is Parkinson&#x2019;s disease a prion-like disorder?</article-title> <source>Mov Disord</source> <volume>28</volume>, <fpage>31</fpage>&#x2013;<lpage>40</lpage>. doi: <pub-id pub-id-type="doi">10.1002/mds.25373</pub-id>.</mixed-citation></ref>
<ref id="c73"><mixed-citation publication-type="journal"><string-name><surname>Oshiro</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Morioka</surname>, <given-names>M. S.</given-names></string-name>, and <string-name><surname>Kikuchi</surname>, <given-names>M.</given-names></string-name> (<year>2011</year>). <article-title>Dysregulation of iron metabolism in Alzheimer&#x2019;s disease, Parkinson&#x2019;s disease, and amyotrophic lateral sclerosis</article-title>. <source>Adv Pharmacol Sci</source> <volume>2011</volume>, <fpage>378278</fpage>.</mixed-citation></ref>
<ref id="c74"><mixed-citation publication-type="journal"><string-name><surname>Park</surname>, <given-names>S. M.</given-names></string-name>, and <string-name><surname>Kim</surname>, <given-names>K. S.</given-names></string-name> (<year>2013</year>). <article-title>Proteolytic clearance of extracellular alpha-synuclein as a new therapeutic approach against Parkinson disease</article-title>. <source>Prion</source> <volume>7</volume>, <fpage>121</fpage>&#x2013;<lpage>126</lpage>. doi: <pub-id pub-id-type="doi">10.4161/pri.22850</pub-id>.</mixed-citation></ref>
<ref id="c75"><mixed-citation publication-type="journal"><string-name><surname>Perez</surname>, <given-names>C. A.</given-names></string-name>, <string-name><surname>Tong</surname>, <given-names>Y.</given-names></string-name>, and <string-name><surname>Guo</surname>, <given-names>M.</given-names></string-name> (<year>2008</year>). <article-title>Iron chelators as potential therapeutic agents for Parkinson&#x2019;s disease</article-title>. <source>Current Bioactive Compounds</source> <volume>4</volume>, <fpage>150</fpage>&#x2013;<lpage>158</lpage>.</mixed-citation></ref>
<ref id="c76"><mixed-citation publication-type="journal"><string-name><surname>Picken</surname>, <given-names>M. M.</given-names></string-name> (<year>2010</year>). <article-title>Fibrinogen amyloidosis: the clot thickens!</article-title> <source>Blood</source> <volume>115</volume>, <fpage>2985</fpage>&#x2013;<lpage>2986</lpage>. doi: <pub-id pub-id-type="doi">10.1182/blood-2009-12-236810</pub-id>.</mixed-citation></ref>
<ref id="c77"><mixed-citation publication-type="journal"><string-name><surname>Pieters</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Covic</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Loots Du</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Van Der Westhuizen</surname>, <given-names>F. H.</given-names></string-name>, <string-name><surname>Van Zyl</surname>, <given-names>D. G.</given-names></string-name>, <string-name><surname>Rheeder</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Jerling</surname>, <given-names>J. C.</given-names></string-name>, and <string-name><surname>Weisel</surname>, <given-names>J. W.</given-names></string-name> (<year>2006</year>). <article-title>The effect of glycaemic control on fibrin network structure of type 2 diabetic subjects</article-title>. <source>Thromb Haemost</source> <volume>96</volume>, <fpage>623</fpage>&#x2013;<lpage>629</lpage>.</mixed-citation></ref>
<ref id="c78"><mixed-citation publication-type="journal"><string-name><surname>Potgieter</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Bester</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name>, and <string-name><surname>Pretorius</surname>, <given-names>E.</given-names></string-name> (<year>2015</year>). <article-title>The dormant blood microbiome in chronic, inflammatory diseases</article-title>. <source>FEMS Microbiol Rev</source> <volume>39</volume>, <fpage>567</fpage>&#x2013;<lpage>591</lpage>. doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/femsre/fuv013">http://dx.doi.org/10.1093/femsre/fuv013</ext-link>.</mixed-citation></ref>
<ref id="c79"><mixed-citation publication-type="other"><string-name><surname>Pretorius</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Akeredolu</surname>, <given-names>O.-O.</given-names></string-name>, <string-name><surname>Soma</surname>, <given-names>P.</given-names></string-name>, and <string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name> (<year>2016a</year>). <article-title>Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability</article-title>. <source>Exp Biol Med, in press</source>.</mixed-citation></ref>
<ref id="c80"><mixed-citation publication-type="journal"><string-name><surname>Pretorius</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Bester</surname>, <given-names>J.</given-names></string-name>, and <string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name> (<year>2016b</year>). <article-title>A bacterial component to Alzheimer-type dementia seen via a systems biology approach that links iron dysregulation and inflammagen shedding to disease</article-title> <source>J Alzheimers Dis</source> <volume>53</volume>, <fpage>1237</fpage>&#x2013;<lpage>1256</lpage>.</mixed-citation></ref>
<ref id="c81"><mixed-citation publication-type="journal"><string-name><surname>Pretorius</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Bester</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Vermeulen</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Alummoottil</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Soma</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Buys</surname>, <given-names>A. V.</given-names></string-name>, and <string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name> (<year>2015</year>). <article-title>Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnostics</article-title>. <source>Cardiovasc Diabetol</source> <volume>13</volume>, <fpage>30</fpage>.</mixed-citation></ref>
<ref id="c82"><mixed-citation publication-type="journal"><string-name><surname>Pretorius</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Bester</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Vermeulen</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Lipinski</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Gericke</surname>, <given-names>G. S.</given-names></string-name>, and <string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name> (<year>2014a</year>). <article-title>Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents</article-title>. <source>PLoS One</source> <volume>9</volume>, <fpage>e85271</fpage>.</mixed-citation></ref>
<ref id="c83"><mixed-citation publication-type="journal"><string-name><surname>Pretorius</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Du Plooy</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Soma</surname>, <given-names>P.</given-names></string-name>, and <string-name><surname>Gasparyan</surname>, <given-names>A. Y.</given-names></string-name> (<year>2014b</year>). <article-title>An ultrastructural analysis of platelets, erythrocytes, white blood cells, and fibrin network in systemic lupus erythematosus</article-title>. <source>Rheumatol Int</source> <volume>34</volume>, <fpage>1005</fpage>&#x2013;<lpage>1009</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00296-013-2817-x</pub-id>.</mixed-citation></ref>
<ref id="c84"><mixed-citation publication-type="journal"><string-name><surname>Pretorius</surname>, <given-names>E.</given-names></string-name>, and <string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name> (<year>2014</year>). <article-title>Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases</article-title>. <source>Integrative Biol</source> <volume>6</volume>, <fpage>486</fpage>&#x2013;<lpage>510</lpage>.</mixed-citation></ref>
<ref id="c85"><mixed-citation publication-type="journal"><string-name><surname>Pretorius</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Mbotwe</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Bester</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Robinson</surname>, <given-names>C.</given-names></string-name>, and <string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name> (<year>2016c</year>). <article-title>Acute induction of anomalous blood clotting by highly substoichiometric levels of bacterial lipopolysaccharide (LPS)</article-title>. <source>bioRxiv</source>, 2016-053538v053531. doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1101/053538">http://dx.doi.org/10.1101/053538</ext-link>.</mixed-citation></ref>
<ref id="c86"><mixed-citation publication-type="journal"><string-name><surname>Pretorius</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Mbotwe</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Bester</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Robinson</surname>, <given-names>C. J.</given-names></string-name>, and <string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name> (<year>2016d</year>). <article-title>Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharide</article-title>. <source>J R Soc Interface</source> <volume>123</volume>, 20160539. doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1098/rsif.2016.0539">http://dx.doi.org/10.1098/rsif.2016.0539</ext-link>.</mixed-citation></ref>
<ref id="c87"><mixed-citation publication-type="journal"><string-name><surname>Pretorius</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Oberholzer</surname>, <given-names>H. M.</given-names></string-name>, <string-name><surname>Van Der Spuy</surname>, <given-names>W. J.</given-names></string-name>, <string-name><surname>Swanepoel</surname>, <given-names>A. C.</given-names></string-name>, and <string-name><surname>Soma</surname>, <given-names>P.</given-names></string-name> (<year>2011a</year>). <article-title>Qualitative scanning electron microscopy analysis of fibrin networks and platelet abnormalities in diabetes</article-title>. <source>Blood Coagul Fibrinol</source> <volume>22</volume>, <fpage>463</fpage>&#x2013;<lpage>467</lpage>. doi: <pub-id pub-id-type="doi">10.1097/MBC.0b013e3283468a0d</pub-id>.</mixed-citation></ref>
<ref id="c88"><mixed-citation publication-type="journal"><string-name><surname>Pretorius</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Oberholzer</surname>, <given-names>H. M.</given-names></string-name>, <string-name><surname>Van Der Spuy</surname>, <given-names>W. J.</given-names></string-name>, <string-name><surname>Swanepoel</surname>, <given-names>A. C.</given-names></string-name>, and <string-name><surname>Soma</surname>, <given-names>P.</given-names></string-name> (<year>2012</year>). <article-title>Scanning electron microscopy of fibrin networks in rheumatoid arthritis: a qualitative analysis</article-title>. <source>Rheumatol Int</source> <volume>32</volume>, <fpage>1611</fpage>&#x2013;<lpage>1615</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00296-011-1805-2</pub-id>.</mixed-citation></ref>
<ref id="c89"><mixed-citation publication-type="journal"><string-name><surname>Pretorius</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Steyn</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Engelbrecht</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Swanepoel</surname>, <given-names>A. C.</given-names></string-name>, and <string-name><surname>Oberholzer</surname>, <given-names>H. M.</given-names></string-name> (<year>2011b</year>). <article-title>Differences in fibrin fiber diameters in healthy individuals and thromboembolic ischemic stroke patients</article-title>. <source>Blood Coagul Fibrinolysis</source> <volume>22</volume>, <fpage>696</fpage>&#x2013;<lpage>700</lpage>. doi: <pub-id pub-id-type="doi">10.1097/MBC.0b013e32834bdb32</pub-id>.</mixed-citation></ref>
<ref id="c90"><mixed-citation publication-type="journal"><string-name><surname>Pretorius</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Swanepoel</surname>, <given-names>A. C.</given-names></string-name>, <string-name><surname>Buys</surname>, <given-names>A. V.</given-names></string-name>, <string-name><surname>Vermeulen</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Duim</surname>, <given-names>W.</given-names></string-name>, and <string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name> (<year>2014c</year>). <article-title>Eryptosis as a marker of Parkinson&#x2019;s disease</article-title>. <source>Aging</source> <volume>6</volume>, <fpage>788</fpage>&#x2013;<lpage>819</lpage>.</mixed-citation></ref>
<ref id="c91"><mixed-citation publication-type="journal"><string-name><surname>Pretorius</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Swanepoel</surname>, <given-names>A. C.</given-names></string-name>, <string-name><surname>Oberholzer</surname>, <given-names>H. M.</given-names></string-name>, <string-name><surname>Van Der Spuy</surname>, <given-names>W. J.</given-names></string-name>, <string-name><surname>Duim</surname>, <given-names>W.</given-names></string-name>, and <string-name><surname>Wessels</surname>, <given-names>P. F.</given-names></string-name> (<year>2011c</year>). <article-title>A descriptive investigation of the ultrastructure of fibrin networks in thrombo-embolic ischemic stroke</article-title>. <source>J Thromb Thrombolysis</source> <volume>31</volume>, <fpage>507</fpage>&#x2013;<lpage>513</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11239-010-0538-5</pub-id>.</mixed-citation></ref>
<ref id="c92"><mixed-citation publication-type="journal"><string-name><surname>Pretorius</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Vermeulen</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Bester</surname>, <given-names>J.</given-names></string-name>, and <string-name><surname>Lipinski</surname>, <given-names>B.</given-names></string-name> (<year>2013a</year>). <article-title>Novel use of scanning electron microscopy for detection of iron-induced morphological changes in human blood</article-title>. <source>Microsc Res Tech</source> <volume>76</volume>, <fpage>268</fpage>&#x2013;<lpage>271</lpage>.</mixed-citation></ref>
<ref id="c93"><mixed-citation publication-type="journal"><string-name><surname>Pretorius</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Vermeulen</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Bester</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Lipinski</surname>, <given-names>B.</given-names></string-name>, and <string-name><surname>Kell</surname>, <given-names>D. B.</given-names></string-name> (<year>2013b</year>). <article-title>A novel method for assessing the role of iron and its functional chelation in fibrin fibril formation: the use of scanning electron microscopy</article-title>. <source>Toxicol Mech Methods</source> <volume>23</volume>, <fpage>352</fpage>&#x2013;<lpage>359</lpage>. doi: <pub-id pub-id-type="doi">10.3109/15376516.2012.762082</pub-id>.</mixed-citation></ref>
<ref id="c94"><mixed-citation publication-type="journal"><string-name><surname>Protopopova</surname>, <given-names>A. D.</given-names></string-name>, <string-name><surname>Barinov</surname>, <given-names>N. A.</given-names></string-name>, <string-name><surname>Zavyalova</surname>, <given-names>E. G.</given-names></string-name>, <string-name><surname>Kopylov</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Sergienko</surname>, <given-names>V. I.</given-names></string-name>, and <string-name><surname>Klinov</surname>, <given-names>D. V.</given-names></string-name> (<year>2015</year>). <article-title>Visualization of fibrinogen alphaC regions and their arrangement during fibrin network formation by high-resolution AFM</article-title>. <source>J Thromb Haemost</source> <volume>13</volume>, <fpage>570</fpage>&#x2013;<lpage>579</lpage>. doi: <pub-id pub-id-type="doi">10.1111/jth.12785</pub-id>.</mixed-citation></ref>
<ref id="c95"><mixed-citation publication-type="journal"><string-name><surname>Rambaran</surname>, <given-names>R. N.</given-names></string-name>, and <string-name><surname>Serpell</surname>, <given-names>L. C.</given-names></string-name> (<year>2008</year>). <article-title>Amyloid fibrils: abnormal protein assembly</article-title>. <source>Prion</source> <volume>2</volume>, <fpage>112</fpage>&#x2013;<lpage>117</lpage>.</mixed-citation></ref>
<ref id="c96"><mixed-citation publication-type="journal"><string-name><surname>Riek</surname>, <given-names>R.</given-names></string-name>, and <string-name><surname>Eisenberg</surname>, <given-names>D. S.</given-names></string-name> (<year>2016</year>). <article-title>The activities of amyloids from a structural perspective</article-title>. <source>Nature</source> <volume>539</volume>, <fpage>227</fpage>&#x2013;<lpage>235</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature20416</pub-id>.</mixed-citation></ref>
<ref id="c97"><mixed-citation publication-type="journal"><string-name><surname>Rodr&#x00ED;guez-Violante</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Camacho-Ordo&#x00F1;ez</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Cervantes-Arriaga</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Gonz&#x00E1;lez-Latap&#x00ED;</surname>, <given-names>P.</given-names></string-name>, and <string-name><surname>Vel&#x00E1;zquez-Osuna</surname>, <given-names>S.</given-names></string-name> (<year>2015</year>). <article-title>Factors associated with the quality of life of subjects with Parkinson&#x2019;s disease and burden on their caregivers</article-title>. <source>Neurologia</source> <volume>30</volume>, <fpage>257</fpage>&#x2013;<lpage>263</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.nrl.2014.01.008</pub-id>.</mixed-citation></ref>
<ref id="c98"><mixed-citation publication-type="journal"><string-name><surname>Rosenbaum</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Aharon-Peretz</surname>, <given-names>J.</given-names></string-name>, and <string-name><surname>Brenner</surname>, <given-names>B.</given-names></string-name> (<year>2013</year>). <article-title>Hypercoagulability, parkinsonism, and Gaucher disease</article-title>. <source>Semin Thromb Hemost</source> <volume>39</volume>, <fpage>928</fpage>&#x2013;<lpage>934</lpage>. doi: <pub-id pub-id-type="doi">10.1055/s-0033-1357485</pub-id>.</mixed-citation></ref>
<ref id="c99"><mixed-citation publication-type="journal"><string-name><surname>Sampson</surname>, <given-names>T. R.</given-names></string-name>, <string-name><surname>Debelius</surname>, <given-names>J. W.</given-names></string-name>, <string-name><surname>Thron</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Janssen</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Shastri</surname>, <given-names>G. G.</given-names></string-name>, <string-name><surname>Ilhan</surname>, <given-names>Z. E.</given-names></string-name>, <string-name><surname>Challis</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Schretter</surname>, <given-names>C. E.</given-names></string-name>, <string-name><surname>Rocha</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Gradinaru</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Chesselet</surname>, <given-names>M.-F.</given-names></string-name>, <string-name><surname>Keshavarzian</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Shannon</surname>, <given-names>K. M.</given-names></string-name>, <string-name><surname>Krajmalnik-Brown</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Wittung-Stafshede</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Knight</surname>, <given-names>R.</given-names></string-name>, and <string-name><surname>Mazmanian</surname>, <given-names>S. K.</given-names></string-name> (<year>2016</year>). <article-title>Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson&#x2019;s disease</article-title>. <source>Cell</source> <volume>167</volume>, <fpage>1469</fpage>&#x2013;<lpage>1480</lpage>.</mixed-citation></ref>
<ref id="c100"><mixed-citation publication-type="journal"><string-name><surname>Sato</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Kaji</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Metoki</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Yoshida</surname>, <given-names>H.</given-names></string-name>, and <string-name><surname>Satoh</surname>, <given-names>K.</given-names></string-name> (<year>2003</year>). <article-title>Coagulation-fibrinolysis abnormalities in patients receiving antiparkinsonian agents</article-title>. <source>J Neurol Sci</source> <volume>212</volume>, <fpage>55</fpage>&#x2013;<lpage>58</lpage>. doi: <pub-id pub-id-type="doi">Doi 10.1016/S0022-510x(03)00101-1</pub-id>.</mixed-citation></ref>
<ref id="c101"><mixed-citation publication-type="journal"><string-name><surname>Schrag</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Jahanshahi</surname>, <given-names>M.</given-names></string-name>, and <string-name><surname>Quinn</surname>, <given-names>N.</given-names></string-name> (<year>2000a</year>). <article-title>How does Parkinson&#x2019;s disease affect quality of life? A comparison with quality of life in the general population</article-title>. <source>Mov Disord</source> <volume>15</volume>, <fpage>1112</fpage>&#x2013;<lpage>1118</lpage>.</mixed-citation></ref>
<ref id="c102"><mixed-citation publication-type="journal"><string-name><surname>Schrag</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Jahanshahi</surname>, <given-names>M.</given-names></string-name>, and <string-name><surname>Quinn</surname>, <given-names>N.</given-names></string-name> (<year>2000b</year>). <article-title>What contributes to quality of life in patients with Parkinson&#x2019;s disease?</article-title> <source>J Neurol Neurosurg Psychiatry</source> <volume>69</volume>, <fpage>308</fpage>&#x2013;<lpage>312</lpage>.</mixed-citation></ref>
<ref id="c103"><mixed-citation publication-type="journal"><string-name><surname>Serpell</surname>, <given-names>L. C.</given-names></string-name>, <string-name><surname>Benson</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Liepnieks</surname>, <given-names>J. J.</given-names></string-name>, and <string-name><surname>Fraser</surname>, <given-names>P. E.</given-names></string-name> (<year>2007</year>). <article-title>Structural analyses of fibrinogen amyloid fibrils</article-title>. <source>Amyloid</source> <volume>14</volume>, <fpage>199</fpage>&#x2013;<lpage>203</lpage>. doi: <pub-id pub-id-type="doi">10.1080/13506120701461111</pub-id>.</mixed-citation></ref>
<ref id="c104"><mixed-citation publication-type="journal"><string-name><surname>Stangou</surname>, <given-names>A. J.</given-names></string-name>, <string-name><surname>Banner</surname>, <given-names>N. R.</given-names></string-name>, <string-name><surname>Hendry</surname>, <given-names>B. M.</given-names></string-name>, <string-name><surname>Rela</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Portmann</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Wendon</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Monaghan</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Maccarthy</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Buxton-Thomas</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Mathias</surname>, <given-names>C. J.</given-names></string-name>, <string-name><surname>Liepnieks</surname>, <given-names>J. J.</given-names></string-name>, <string-name><surname>O&#x2019;grady</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Heaton</surname>, <given-names>N. D.</given-names></string-name>, and <string-name><surname>Benson</surname>, <given-names>M. D.</given-names></string-name> (<year>2010</year>). <article-title>Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation</article-title>. <source>Blood</source> <volume>115</volume>, <fpage>2998</fpage>&#x2013;<lpage>3007</lpage>. doi: <pub-id pub-id-type="doi">10.1182/blood-2009-06-223792</pub-id>.</mixed-citation></ref>
<ref id="c105"><mixed-citation publication-type="journal"><string-name><surname>Stocchi</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Carbone</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Inghilleri</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Monge</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Ruggieri</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Berardelli</surname>, <given-names>A.</given-names></string-name>, and <string-name><surname>Manfredi</surname>, <given-names>M.</given-names></string-name> (<year>1997</year>). <article-title>Urodynamic and neurophysiological evaluation in Parkinson&#x2019;s disease and multiple system atrophy</article-title>. <source>J Neurol Neurosurg Psychiatry</source> <volume>62</volume>, <fpage>507</fpage>&#x2013;<lpage>511</lpage>.</mixed-citation></ref>
<ref id="c106"><mixed-citation publication-type="journal"><string-name><surname>Sulatskaya</surname>, <given-names>A. I.</given-names></string-name>, <string-name><surname>Kuznetsova</surname>, <given-names>I. M.</given-names></string-name>, and <string-name><surname>Turoverov</surname>, <given-names>K. K.</given-names></string-name> (<year>2011</year>). <article-title>Interaction of thioflavin T with amyloid fibrils: stoichiometry and affinity of dye binding, absorption spectra of bound dye</article-title>. <source>J Phys Chem B</source> <volume>115</volume>, <fpage>11519</fpage>&#x2013;<lpage>11524</lpage>. doi: <pub-id pub-id-type="doi">10.1021/jp207118x</pub-id>.</mixed-citation></ref>
<ref id="c107"><mixed-citation publication-type="journal"><string-name><surname>Tipping</surname>, <given-names>K. W.</given-names></string-name>, <string-name><surname>Van Oosten-Hawle</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Hewitt</surname>, <given-names>E. W.</given-names></string-name>, and <string-name><surname>Radford</surname>, <given-names>S. E.</given-names></string-name> (<year>2015</year>). <article-title>Amyloid Fibres: Inert End-Stage Aggregates or Key Players in Disease?</article-title> <source>Trends Biochem Sci</source> <volume>40</volume>, <fpage>719</fpage>&#x2013;<lpage>727</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tibs.2015.10.002</pub-id>.</mixed-citation></ref>
<ref id="c108"><mixed-citation publication-type="journal"><string-name><surname>Tlaskalov&#x00E1;-Hogenov&#x00E1;</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>&#x0160;t&#x011B;p&#x00E1;nkov&#x00E1;</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Koz&#x00E1;kov&#x00E1;</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Hudcovic</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Vannucci</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Tu&#x010D;kov&#x00E1;</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Rossmann</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Hrn&#x010D;ir</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Kverka</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Z&#x00E1;kostelsk&#x00E1;</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Klime&#x0161;ov&#x00E1;</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>P&#x0159;ibylov&#x00E1;</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>B&#x00E1;rtov&#x00E1;</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Sanchez</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Fundov&#x00E1;</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Borovsk&#x00E1;</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>&#x0160;r&#x016F;tkov&#x00E1;</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Z&#x00ED;dek</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Schwarzer</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Drastich</surname>, <given-names>P.</given-names></string-name>, and <string-name><surname>Funda</surname>, <given-names>D. P.</given-names></string-name> (<year>2011</year>). <article-title>The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases</article-title>. <source>Cell Mol Immunol</source> <volume>8</volume>, <fpage>110</fpage>&#x2013;<lpage>120</lpage>. doi: <pub-id pub-id-type="doi">10.1038/cmi.2010.67</pub-id>.</mixed-citation></ref>
<ref id="c109"><mixed-citation publication-type="journal"><string-name><surname>Tycko</surname>, <given-names>R.</given-names></string-name>, and <string-name><surname>Wickner</surname>, <given-names>R. B.</given-names></string-name> (<year>2013</year>). <article-title>Molecular structures of amyloid and prion fibrils: consensus versus controversy</article-title>. <source>Acc Chem Res</source> <volume>46</volume>, <fpage>1487</fpage>&#x2013;<lpage>1496</lpage>. doi: <pub-id pub-id-type="doi">10.1021/ar300282r</pub-id>.</mixed-citation></ref>
<ref id="c110"><mixed-citation publication-type="journal"><string-name><surname>Undas</surname>, <given-names>A.</given-names></string-name>, and <string-name><surname>Ari&#x00EB;ns</surname>, <given-names>R. a. S.</given-names></string-name> (<year>2011</year>). <article-title>Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases</article-title>. <source>Arterioscler Thromb Vasc Biol</source> <volume>31</volume>, <fpage>e88</fpage>&#x2013;<lpage>99</lpage>. doi: <pub-id pub-id-type="doi">10.1161/ATVBAHA.111.230631</pub-id>.</mixed-citation></ref>
<ref id="c111"><mixed-citation publication-type="journal"><string-name><surname>Uversky</surname>, <given-names>V. N.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>J.</given-names></string-name>, and <string-name><surname>Fink</surname>, <given-names>A. L.</given-names></string-name> (<year>2001</year>). <article-title>Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular link between Parkinson&#x2019;s disease and heavy metal exposure</article-title>. <source>J Biol Chem</source> <volume>276</volume>, <fpage>44284</fpage>&#x2013;<lpage>44296</lpage>.</mixed-citation></ref>
<ref id="c112"><mixed-citation publication-type="journal"><string-name><surname>Valko</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Morris</surname>, <given-names>H.</given-names></string-name>, and <string-name><surname>Cronin</surname>, <given-names>M. T. D.</given-names></string-name> (<year>2005</year>). <article-title>Metals, toxicity and oxidative stress</article-title>. <source>Curr Med Chem</source> <volume>12</volume>, <fpage>1161</fpage>&#x2013;<lpage>1208</lpage>.</mixed-citation></ref>
<ref id="c113"><mixed-citation publication-type="confproc"><string-name><surname>Vilar</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Chou</surname>, <given-names>H. T.</given-names></string-name>, <string-name><surname>Luhrs</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Maji</surname>, <given-names>S. K.</given-names></string-name>, <string-name><surname>Riek-Loher</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Verel</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Manning</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Stahlberg</surname>, <given-names>H.</given-names></string-name>, and <string-name><surname>Riek</surname>, <given-names>R.</given-names></string-name> (<year>2008</year>). <article-title>The fold of alpha-synuclein fibrils</article-title>. <conf-name>Proc Natl Acad Sci U S A</conf-name> <volume>105</volume>, <fpage>8637</fpage>&#x2013;<lpage>8642</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0712179105</pub-id>.</mixed-citation></ref>
<ref id="c114"><mixed-citation publication-type="journal"><string-name><surname>Weigandt</surname>, <given-names>K. M.</given-names></string-name>, <string-name><surname>White</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Chung</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Ellingson</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Fu</surname>, <given-names>X. Y.</given-names></string-name>, and <string-name><surname>Pozzo</surname>, <given-names>D. C.</given-names></string-name> (<year>2012</year>). <article-title>Fibrin clot structure and mechanics associated with specific oxidation of methionine residues in fibrinogen</article-title>. <source>Biophys J</source> <volume>103</volume>, <fpage>2399</fpage>&#x2013;<lpage>2407</lpage>. doi: <pub-id pub-id-type="doi">DOI 10.1016/j.bpj.2012.10.036</pub-id>.</mixed-citation></ref>
<ref id="c115"><mixed-citation publication-type="journal"><string-name><surname>Weinreb</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Mandel</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Youdim</surname>, <given-names>M. B. H.</given-names></string-name>, and <string-name><surname>Amit</surname>, <given-names>T.</given-names></string-name> (<year>2013</year>). <article-title>Targeting dysregulation of brain iron homeostasis in Parkinson disease by iron chelators</article-title>. <source>Free Radic Biol Med</source> <volume>62</volume>, <fpage>52</fpage>&#x2013;<lpage>64</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2013.01.017</pub-id>.</mixed-citation></ref>
<ref id="c116"><mixed-citation publication-type="journal"><string-name><surname>Weisel</surname>, <given-names>J. W.</given-names></string-name> (<year>2005</year>). <article-title>Fibrinogen and fibrin</article-title>. <source>Adv Protein Chem</source> <volume>70</volume>, <fpage>247</fpage>&#x2013;<lpage>299</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0065-3233(05)70008-5</pub-id>.</mixed-citation></ref>
<ref id="c117"><mixed-citation publication-type="journal"><string-name><surname>Wolberg</surname>, <given-names>A. S.</given-names></string-name> (<year>2007</year>). <article-title>Thrombin generation and fibrin clot structure</article-title>. <source>Blood Rev</source> <volume>21</volume>, <fpage>131</fpage>&#x2013;<lpage>142</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.blre.2006.11.001</pub-id>.</mixed-citation></ref>
<ref id="c118"><mixed-citation publication-type="journal"><string-name><surname>Wolberg</surname>, <given-names>A. S.</given-names></string-name> (<year>2012</year>). <article-title>Determinants of fibrin formation, structure, and function</article-title>. <source>Curr Opin Hematol</source> <volume>19</volume>, <fpage>349</fpage>&#x2013;<lpage>356</lpage>. doi: <pub-id pub-id-type="doi">10.1097/MOH.0b013e32835673c2</pub-id>.</mixed-citation></ref>
<ref id="c119"><mixed-citation publication-type="journal"><string-name><surname>Yermolenko</surname>, <given-names>I. S.</given-names></string-name>, <string-name><surname>Lishko</surname>, <given-names>V. K.</given-names></string-name>, <string-name><surname>Ugarova</surname>, <given-names>T. P.</given-names></string-name>, and <string-name><surname>Magonov</surname>, <given-names>S. N.</given-names></string-name> (<year>2011</year>). <article-title>High-resolution visualization of fibrinogen molecules and fibrin fibers with atomic force microscopy</article-title>. <source>Biomacromolecules</source> <volume>12</volume>, <fpage>370</fpage>&#x2013;<lpage>379</lpage>. doi: <pub-id pub-id-type="doi">10.1021/bm101122g</pub-id>.</mixed-citation></ref>
<ref id="c120"><mixed-citation publication-type="journal"><string-name><surname>Zhmurov</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Brown</surname>, <given-names>A. E.</given-names></string-name>, <string-name><surname>Litvinov</surname>, <given-names>R. I.</given-names></string-name>, <string-name><surname>Dima</surname>, <given-names>R. I.</given-names></string-name>, <string-name><surname>Weisel</surname>, <given-names>J. W.</given-names></string-name>, and <string-name><surname>Barsegov</surname>, <given-names>V.</given-names></string-name> (<year>2011</year>). <article-title>Mechanism of fibrin(ogen) forced unfolding</article-title>. <source>Structure</source> <volume>19</volume>, <fpage>1615</fpage>&#x2013;<lpage>1624</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.str.2011.08.013</pub-id>.</mixed-citation></ref>
<ref id="c121"><mixed-citation publication-type="journal"><string-name><surname>Zhmurov</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Kononova</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Litvinov</surname>, <given-names>R. I.</given-names></string-name>, <string-name><surname>Dima</surname>, <given-names>R. I.</given-names></string-name>, <string-name><surname>Barsegov</surname>, <given-names>V.</given-names></string-name>, and <string-name><surname>Weisel</surname>, <given-names>J. W.</given-names></string-name> (<year>2012</year>). <article-title>Mechanical transition from alpha-helical coiled coils to beta-sheets in fibrin(ogen)</article-title>. <source>J Am Chem Soc</source> <volume>134</volume>, <fpage>20396</fpage>&#x2013;<lpage>20402</lpage>. doi: <pub-id pub-id-type="doi">10.1021/ja3076428</pub-id>.</mixed-citation></ref></ref-list></back></article>